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1.1 Radiotherapy 
 
According to the World Health Organization, cancer is the leading cause of death around the 
world. In 2008, it was estimated that there were about 12.7 million new cancer cases and 7.6 
million cancer deaths [1]. In the Netherlands alone, around 86,800 new cancer cases were 
reported in 2007 and it is projected to rise to about 123,000 in 2020 [2]. Radiotherapy is one 
of the main treatment options for cancer. The aim of radiotherapy is to destroy cancerous 
cells while minimizing damage to the surrounding normal tissues.  As normal tissues are able 
to repair radiation damage better than cancer cells, a certain amount of dose delivered in 
multiple fractions can effectively kill cancer cells, while sparing normal tissues. This 
technique has been used as a cancer treatment by Emiel Grubbe [3] soon after the discovery 
of X-rays by Wilhelm Röntgen in 1895 [4]. Since then, the art of radiation delivery has 
evolved through the ages. Radiation therapy was traditionally delivered using radioactive 
elements such as radium-226, which produces photons in the form of gamma rays at an 
average energy of 0.83 MeV. In mid 1900s, radium was replaced by cobalt-60 in cancer 
treatment due to its higher gamma ray energies (1.17 and 1.33 MeV). The first external beam 
radiotherapy unit using Cobalt-60 was installed in 1951. It was widely adopted since x-ray 
generators were only capable of generating x-rays at voltages up to 300 KV at that period.  
 
The use of x-ray generators took a major step forward in 1953 when the first medical linear 
accelerator (linac) which could generate X-rays up to 8MV became available [5]. Although 
the maximum X-ray energy is 8 MeV for an 8MV X-ray beam, the mean energy was much 
lower, in the order of approximately 3 MeV. The megavoltage linac had the advantages of 
generating a higher penetrating energy, higher dose rate, lack of a physical radiation source 
and better capability of delivering a uniform dose. Although the initial linacs did not have a 
gantry that could rotate around the patient, in 1960, the first full rotational isocentric linac 
was released. Despite the evident advantages of linacs, Cobalt-60 units were still widely used 
because of the low cost of these machines. As technology advanced, the design of the linac 
was simplified and the cost was reduced to be competitive with the Cobalt-60 units. In 
subsequent decades, linacs began to replace Co-60 unit and have now become the standard in 
external beam radiation therapy treatment.  
 
Conventional radiotherapy delivery commonly uses the combination of two or more open 
fields. Parallel opposed fields (Fig. 1a) is the simplest technique [6], and it is still being used 
for fast treatment planning and delivery, mainly for palliative treatments [7,8]. Among the 
advantages of parallel opposed fields are simplicity, less chance of geometric miss and 
homogenous dose to the target volume (Fig. 2a). However, the latter is depending on the 
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patient thickness, beam energy and beam profile. A combination of the simple field setting 
and a flat beam profile allows for a manual calculation of the isodose distribution if it is 
assumed that all tissues are water equivalent.  
 
 
CR - Couch Rotation; GA – Gantry Angle; GS – Gantry Rotation Speed during beam on; DR – Dose rate during beam on  
Figure 1. Beam settings and apertures for two of the fields of different delivery techniques on a Varian Trilogy 
linac with maximum dose rate of 600 MU/min. a. 2 parallel opposed fields without MLC, b. 8-12 fields 3D non-
coplanar static conformal radiotherapy. c. RapidArc dynamic rotational delivery using variable gantry speed, 
dose rate and MLC apertures.  
 
The main disadvantages of parallel opposed fields technique are the relatively high skin 
doses, and limited sparing of normal tissues. Increasing the number of fields can provide a 
more conformal dose distribution (Fig. 2b), although it was more time consuming to obtain 
an optimal plan manually. In the late 1960s, beam modifiers such as wedges and blocks were 
used to modify the beam. A wedge attenuates radiation at one edge of the field, resulting in 
tilted isodose curves, whereas blocks, made of lead [9] or Lipowitz’s metal [10], were shaped 
to follow certain geometrical outlines to shield the vital organs.  The shielding blocks used 
were custom-made for each patient and each beam angle. It required intensive labor effort 
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and therapist had to repeatedly visit the treatment room to manually change the blocks for 
each beam [11].  
 
 
Figure 2: Dose distributions for a patient with lung tumor measuring 161 cm3 generated using: a. Parallel 
opposed fields; b. multiple fields setting; c. 3D non-coplanar static conformal radiotherapy; d. intensity 
modulated radiotherapy; e. RapidArc, for a prescription dose of 55 Gy.  
 
In order to deliver the required high doses to the target volume while sparing the healthy 
tissues, a precise target volume definition is vital. A clinical x-ray computed tomographic 
scan (CT) prototype was developed by Godfrey Hounsfield in 1972.  In the subsequent years, 
CT technology vastly improved in speed and image quality. With a better imaging technique, 
the art of radiation delivery leapt into a 3D era. Three-dimensional conformal radiation 
therapy (3D-CRT) is a technique to generate and deliver a dose distribution conformal to the 
target’s size and shape with the assistance of computerized planning and dose calculation. 
3D-CRT can provide better dose conformity around the target volume (Fig. 2c), and thus, 
reducing doses to the normal tissues. 3D-CRT dose distribution can be delivered by defining 
the beam aperture accordingly to the outline of the target volume using a multileaf collimator 
(MLC, Fig. 1b), where each leaf with a certain thickness is driven by an individual motor. 
The ability of an MLC to automatically alter the beam apertures made the delivery of 
complex multi-fields treatment delivery more practical and less labor intensive [12].  
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1.2 Stereotactic body radiotherapy 
 
Comparisons between 3D-CRT and conventional 2D-techniques showed significantly better 
sparing of the organs at risk (OAR) with the former, which consequently was shown to 
decrease the incidence of acute and late morbidity [13-15]. With more conformal dose 
distribution, a higher dose could be delivered to the target volume without increasing the risk 
of complications [16].  
 
Early radiotherapy treatments in the early 1900s consisted of single high doses of radiation 
with associated severe side effects. In 1922, Claudius Regaud proved that fractionated 
therapy was as effective as single-dose, but greatly reduced the side effects [17]. Over the 
years, for most radiotherapy treatments with curative intend, 10 - 40 fractions became the 
standard. In 1951, a non-invasive treatment of diseased or dysfunctional tissue with a single 
large dose of radiation using a stereotactic apparatus was introduced by Lars Leksell [18]. 
The method, stereotactic radiosurgery (SRS), irradiated a series of narrow beams from 
different angles to produce a focal effect at the lesion, thus, minimizing the dose to the 
surrounding tissue. This technique requires high geometric accuracy and precision for 
isocenter localization.  
 
SRS gained considerable popularity following the advances of CT technology in the 1980s. 
Initially developed to treat lesions in the brain, SRS was later extended to treat lesions in 
other parts of body where it was called stereotactic body radiotherapy (SBRT). Although 
there is no definite definition for SBRT, it is generally characterized by the definition of a 
single or limited number of fractions using multiple coplanar or non-coplanar field or arcs to 
deliver a high dose precisely to the tumor, while sparing the surrounding healthy tissues. 
Since mid 1990s, linac-based SBRT has been used for treating stage I non-small cell lung 
cancer, spinal and liver metastases [19-21].  
 
1.3 Intensity Modulated Radiotherapy 
 
Despite acceptable dose conformity obtained with 3D-CRT, it can be insufficient for irregular 
target volumes particularly when they are in the proximity of critical organs. 3D-CRT utilized 
so-called “forward planning”, which required the planner to decide on number of beams, 
weights and beam orientation to be used. With the use of oblique beam angles and/or couch 
rotations, the planning process could be time consuming and sometimes did not lead to an 
optimal plan.   
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With advances in computer technology, intensity modulated radiotherapy (IMRT) was 
introduced in the late 1990s. IMRT is a technique that delivers highly conformal dose 
distributions to the target by creating non-uniform radiation beam intensities across each 
irradiation field (Fig. 2d). It incorporates two distinct features to deliver 3D conformal dose 
distribution: inverse planning performed by the computer and computer-controlled intensity 
modulation during beam delivery. Inverse planning optimization required the planner to 
define a set of planning objectives or dose constraints to the target volume and organs at risk. 
Each plan constraint is assigned with a priority value which reflects the importance of the 
dose distribution to meet that constraint. Based on the input of these constraints and the basic 
beam data of the linacs, the optimization algorithm generates a fluence map using an iterative 
method in order to optimize the intensity profile of each beam. At each iteration step, an 
objective function is obtained based upon the square deviation between the desired and 
computed dose distribution [22]. The goal of the optimization is to reach the minimum of the 
objective function. The optimized fluence maps are then converted into a set of leaf sequence 
files that control the movement of the MLC during delivery.  
 
Currently, different modalities can be used to delivery an IMRT dose distribution (Fig. 3). 
IMRT can be delivered with a linac using segmental IMRT (step and shoot) [23] or dynamic 
IMRT (sliding window) [24,25], or with a tomotherapy [26] or Cyberknife unit [27,28]. Step 
and shoot techniques use a series of beams, which consist of several overlapping static MLC 
fields to create the non-uniform beam intensity. The radiation delivery is suspended while the 
MLC leafs move to shape the segments. For sliding window technique, each MLC leaf pair 
shifts continuously at a variable speed while the beam is at a fixed gantry angle. The setting 
of the leaf openings and the MLC speed determine the intensity profile of each beam. 
Tomotherapy, on the other hand, delivers radiation using rotational delivery. The unit uses a 
binary collimator to control the amount of exposure time of a small width of the fan beam, 
which determines the intensity of the beam at that particular angle. The beam can be 
irradiated with discrete table increments between each axial gantry arc (serial tomotherapy) 
[29], or using a continuous synchronized gantry and table motion (helical tomotherapy) [26]. 
Cyberknife unit uses pencil beams radiation and different dose intensities can be achieved by 
superpositioning the pencil beams from different angles with the help of a robotic arm.  
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Figure 3. Different modalities and techniques used for intensity modulated radiotherapy treatment.  
 
A number of authors have performed treatment planning comparisons between IMRT and 
3D-CRT for several indications. IMRT has been reported to obtain better dose conformity 
and lower doses to the OAR [30-35]. With a more conformal dose distribution, it is then 
possible to decrease exposure in the surrounding normal tissues, thus reducing acute toxicity, 
or increasing the dose to the tumor target, thus potentially reducing local recurrence rates. 
Zelefsky et al. followed a series of 1571 patients with prostate cancer treated with 3D-CRT or 
IMRT and reported that the use of IMRT significantly reduced the risk of gastrointenstinal 
toxicities [36]. Luxton et al also suggested that IMRT delivery for prostate cancer can limit 
dose to normal tissue compared to 3D-CRT, and consequently reduces normal tissue 
complications while maintaining or increasing tumor control probability due to smaller 
number of fraction required and greater mean target dose per fraction [37]. 
 
While there are many potential advantages to IMRT, a number of undesired effects also exist. 
Intensity modulation of IMRT results in more complex plans leading to prolonged planning 
and delivery time, and an increase in the number of MU. The extra MU generated increases 
total body exposure due to leakage radiation from the head of the linac. Hall et al. suggested 
that this can increase the risk of secondary cancers, especially for younger patients who may 
have longer survival [38]. In addition, although IMRT may reduce the risk of secondary 
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cancers by reducing the volume of tissues exposed to high doses, it may also increase such 
risk due to exposing larger volumes to lower doses [39-41]. In general, the delivery time of 
IMRT is 2 – 6 times longer than for 3D-CRT. A longer delivery time is associated with the 
risk of patient intrafraction baseline shifts [42]. For IMRT delivery to mobile targets, the 
motion of the MLC leafs and tumors can lead to an interplay effect which may cause hot/cold 
spots of dose within the target volume, resulting in dose variation of up to 18% in a single 
fraction [43]. Although it has been suggested that the dose variations would decrease to 1 – 
2% if treatments were delivered in 30 fractions [44], this might not be applicable for SBRT 
delivery which is generally completed in 3 – 8 fractions.  
 
In 2008, Varian Medical Systems clinically introduced RapidArcTM as a new radiation 
delivery technique with inverse planning optimization. RapidArc, based on an investigation 
from Karl Otto [45], is a form of volumetric modulated arc therapy that delivers a complete 
IMRT dose distribution in a single gantry rotation (Fig. 2e). It aims to improve target 
coverage and sparing of healthy tissues while reducing the treatment delivery time as 
compared to other IMRT techniques. By simultaneously modulating the aperture shape with 
dynamic MLC, dose rate and gantry speed during delivery (Fig. 1c), a highly conformal dose 
distribution can be achieved (Fig. 4). RapidArc plans are generated using the progressive 
resolution algorithm (PRO). It uses a similar concept as direct aperture optimization [46], 
where the MLC leaf positions and aperture weights are optimized directly. The mechanical 
limitation such as maximum dose rate, gantry rotation speed and leaf translation speed are 
considered by PRO during optimization. To speed up the process, early versions of PRO (up 
to Eclipse v8.9) begin with a small number of control points and gradually increases up to a 
maximum of 177 control points for a full gantry rotation delivery. Since Eclipse v10, a new 
PRO has been introduced that can optimize plans faster than the earlier versions and 
optimization starts at all control points from the beginning of the optimization [47]. 
 
When an accelerated electron beam hits the scatter foil in the head of the linac, a mostly 
forward directed X-ray distribution is created. Its fluence profile is conically shaped. A 
flattening filter is inserted in the treatment head to create a flattened beam profile to produce 
approximately uniform dose distribution across the field at a certain depth in a homogeneous 
phantom. It is particularly useful for conventional techniques such as parallel opposed fields 
to produce a homogeneous dose distribution within the target and for the ease of manual dose 
calculation. In modern radiotherapy using inverse planning, the basic beam data is taken into 
account during the optimization process. As a result, a flattened (FF) beam is not necessary 
for IMRT delivery, and flattening filter free (FFF) beams were introduced in clinical practice 
[48,49]. The removal of flattening filter produces a higher dose rate and lower out-of-field 
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doses [50]. Consequently, it shortens the beam-on time [51], reduces the peripheral doses in 
patients [52] and also doses outside the treatment room [50]. The significant reduction in 
treatment time suggests that FFF in combination with RapidArc delivery can be beneficial for 
certain SBRT treatments.  
 
 
Figure 4. A highly conformal dose distribution with better sparing of the chest wall generated using RapidArc 
(middle) compared to those created using 3D static non-coplanar conformal radiotherapy (left) and dynamic 
conformal arc technique (right). 
 
All modern radiotherapy delivery techniques have proven the ability to create a sharp dose 
gradient outside the target volume, but this also results in treatments that are particularly 
sensitive to geometrical uncertainties, which arise from the uncertainties of imaging, target 
definition, patient positional setup and stability. For accurate patient positioning, image 
guided radiotherapy (IGRT) is utilized. IGRT is the process of incorporating imaging 
coordinates from the treatment plan to facilitate patient position verification during treatment 
delivery. Nowadays, IGRT can be performed with the aid of many different imaging 
techniques such as ultrasound [53,54], 2D X-ray devices [55,56], 3D cone-beam CT scans 
(CBCT) [57,58] or magnetic resonance imaging (MRI) [59,60]. The use of IGRT devices 
such as CBCT which improve soft tissue image quality also enable positional setup based on 
tumor match instead of bony anatomical structures.  Most techniques allow in-room pre-
treatment imaging and assessment in patient positioning relative to treatment plans. An 
appropriate choice of IGRT devices and protocols is important to ensure an optimum 
treatment outcome.   
 
1.4 Dose Calculation 
 
Prior to the CT-era, dose calculations were generally carried out manually. Dose distributions 
were drafted by overlaying standard isodose charts on to the patient’s body contours. From 
1990s onwards, accessible computing power led to the development of CT based 
computerized treatment planning systems (TPS). When a TPS is commissioned, all beam data 
from local linacs must be acquired and entered into the system. The beam data will be used 
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by calculation algorithms to construct dose distributions projected on the CT-slices of the 
patient.  
 
The pencil beam convolution algorithm (PBC) [61] has been the most widely used model for 
photon dose calculations. In PBC, a pencil beam kernel describes the deposition of energy 
around a very narrow beam. The dose distribution from a treatment field is computed by 
dividing the field into narrow beams and combining their contribution over the entire field 
area. The kernels can be pre-calculated using e.g. Monte Carlo simulations, a method which 
simulates the exact interaction probabilities of electrons and photons. For tissue 
inhomogeneity, methods such as modified Batho [62] or equivalent path length correction 
[63] have been applied. However, both of them do not take into account variations in density 
at a position lateral to the calculation point.   
 
Even though PBC showed sufficient calculation accuracy in water equivalent or higher 
density media, some authors have reported dose errors in low density material [64], and 
deviations of more than 15% were reported in a heterogeneous phantom containing lung 
equivalent material [65]. Engelsman et al. also demonstrated that PBC algorithms predicted a 
considerably higher dose in lung, which may lead to an underdosage of the target volume of 
up to 20% during actual treatment [66]. The errors tend to increase for smaller irradiated field 
sizes in combination with higher beam energy [64] or when the density of the media 
decreases [67].   
 
For more accurate dose calculation, more sophisticated convolution-superposition based 
algorithms such as collapsed cone convolution (CCC) [68] and analytical anisotropic 
algorithm (AAA) [69] have been implemented. Both algorithms have shown superior 
accuracy in comparison to PBC [70-72]. AAA is based on a pencil-beam 
convolution/superposition technique which was originally developed to overcome the 
shortcomings of PBC. It uses Monte Carlo derived energy deposition kernels and has separate 
modeling for primary photons, scattered extra-focal photons and contaminant electrons. 
Tissue inhomogeneities are accounted for at both longitudinal and lateral directions of the 
beam [73]. During dose calculation, the patient’s body volume is divided into voxels and the 
clinical beam is divided into small beamlets where the cross section of the beamlet matches 
the voxel. The final dose distribution is obtained by a superposition of the dose contribution 
from every individual beamlet.  
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1.5 Aim of thesis 
 
The aim of the work performed in this thesis is to evaluate the use of RapidArc treatment 
planning and delivery, using the Eclipse TPS for SBRT in terms of dose calculation, delivery 
accuracy and delivery time. In addition, the advantages and disadvantages of FFF beams are 
evaluated. 
 
Chapter 2 and 3 describe the advantage and risk of RapidArc for SBRT delivery for small 
and larger non-small cell lung cancers. Chapter 2 focuses on the treatment planning of 
RapidArc for Stage I NSCLC patients with tumors measuring < 70 cm3. The plans were 
compared with other conventional techniques such as dynamic conformal arc, non-coplanar 
static conformal fields and IMRT, in term of dose conformity, OAR sparing and delivery 
time. For patients with tumors > 70 cm3, 18 consecutive patients who had completed SBRT 
using RapidArc were analyzed. The correlations of different dosimetric parameters with the 
risk of symptomatic radiation pneumonitis are presented in Chapter 3. A major concern with 
intensity modulated based radiation delivery in mobile targets is the potential interplay 
between respiration induced tumor motion and MLC leaf motion. The delivery accuracy and 
possible interplay effects of single fraction RapidArc delivery for lung tumors are examined 
in Chapter 4.  
 
For some complex cases, the TPS is likely to generate plans with a large number of small 
effective leaf openings. In Chapter 5, we studied the accuracy of two versions of AAA, each 
with two resolutions of the calculation grid, for a variety of small fields in both homogeneous 
and heterogeneous media, and for RapidArc plans. The dosimetric accuracy in selected 
clinical cases was also evaluated. Chapter 6 explores the use of FFF beams to deliver 
RapidArc plans for NSCLC and spinal metastasis cases. The quality of plans and delivery 
time were compared to standard RapidArc plans generated with flattened beam profiles and 
the delivery accuracy of FFF RapidArc plans was investigated. 
 
The use of FFF beams with higher dose rate can significantly reduce the delivery time for 
treatment of vertebral SBRT. With 2400 MU/min, a maximum of 1 Gy can be delivered over 
approximately 3 seconds, even for small leaf openings. In Chapter 7, we studied the 
dosimetric differences caused by intrafraction shifts of varying magnitude and duration for 
three vertebral SBRT cases. Possible impact on both spinal cord and target volume dosimetry 
were evaluated for plans delivered using FFF or standard flattened beams.  
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Abstract 
 
Purpose: Volumetric modulated arc therapy (RapidArc) allows for fast delivery of 
stereotactic body radiotherapy (SBRT) delivery in stage I lung tumors. We compared dose 
distributions and delivery times between RapidArc and common delivery techniques in small 
tumors.  
 
Methods: In 18 patients who completed RapidArc SBRT for tumors measuring <70 cm3, 
new treatment plans were generated using non-coplanar 3D conformal fields (conf-SBRT) 
and dynamic conformal arc radiotherapy (DCA). For 9 patients with tumors adjacent to the 
chest wall, co-planar intensity-modulated radiotherapy (IMRT) plans were also generated. 
PTV dose coverage, organs at risk (OAR) doses and treatment delivery times were assessed. 
 
Results: RapidArc plans achieved a superior conformity index (CI) and lower V45Gy to chest 
wall (p<0.05) compared to all other techniques. RapidArc led to a small increase in V5Gy to 
contralateral lung compared to conf-SBRT (4.4±4% versus 1.2±1.8%, p=0.011). For other 
OAR, RapidArc and conf-SBRT plans were comparable, and both were superior to DCA 
plans. Delivery of a 7.5Gy-fraction required 3.9 minutes (RapidArc), 11.6 minutes (conf-
SBRT), and 12 minutes (IMRT). 
 
Conclusions: In stage I lung tumors measuring <70 cm3, RapidArc plans achieved both the 
highest dose conformity and shortest delivery times. 
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Introduction 
 
In patients presenting with stage I non-small cell lung cancer (NSCLC) who are unfit to 
undergo surgery, stereotactic body radiotherapy (SBRT) has achieved far superior local 
control rates than were reported using conventionally fractionated radiotherapy [1]. Reported 
three-year local controls rates range from 88% to 92% [2,3], and when risk-adapted 
fractionation schemes are used, with high local control rates achieved with minimal toxicity 
[4]. On longer follow-up, however, more late toxicity including rib fractures and injuries to 
the brachial plexus are being observed [5-7], suggesting that further improvements in dose 
conformality are desirable. 
 
SBRT is commonly delivered using multiple static beams, sometimes in combination with 
dynamic arcs. Although the use of non-coplanar delivery techniques can increase the dose 
conformity, it also prolongs the delivery time for SBRT. Intensity modulated radiotherapy 
(IMRT) can improve dose conformity further, but at the cost of longer delivery times. SBRT 
deliver times, including time required for patient set-up and delivery, typically range between 
22 minutes [8] and 100 minutes [9], depending on equipment used and delivered doses used. 
The magnitude and probability of a tumor base line shift from the initial setup to the end of 
the treatment increases with extended delivery times [10,11]. Faster SBRT delivery is 
therefore not only patient-friendly, but also improves treatment accuracy and allows for more 
efficient use of departmental resources. 
 
RapidArc (Varian Medical Systems) is a form of volumetric modulated arc therapy, which 
delivers the dose in a maximum of 358° gantry rotation with varying openings of the multi-
leaf collimator (MLC), dose rates and gantry speed [12]. RapidArc has been shown to 
improve treatment-time efficiency, produce highly conformal dose distributions and achieve 
accurate dosimetric delivery [13-16]. Primarily due to the speed of delivery, RapidArc has 
been implemented as our standard technique for the treatment of stage I lung tumors [17]. In 
order to quantify the benefits in comparisons to other commonly used techniques, dose 
distribution and delivery time for each SBRT technique were studied in a larger cohort of 
patients who had completed treatment using RapidArc.  
 
Materials and methods 
 
Patient characteristics 
18 patients with stage I NSCLC who had completed RapidArc at our center since September 
2008, and whose PTV was 70 cm3 or less, were identified. The size criterion was based upon 
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the fact that nearly 90% of the tumors treated by us and others were smaller than 70 cm3 [2-
4]. Tumor characteristics are summarized in Table I, and the mean planning target volume 
(PTV) was 33.7 cm3 (range 6.3- 67.1 cm3). Plans for cases 1 – 3 were also reported in an 
earlier publication [17]. 
 
Imaging and target definition 
All patients were imaged and treated during uncoached respiration, and respiration-gated 
delivery was not used. All patients underwent a single four-dimensional (4D) CT-scan that 
was performed in supine position with arms above the head using an arm rest. The images 
were reconstructed in ten equally spaced time bins using respiratory phase binning as 
previously described [18]. An internal target volume (ITV) was delineated taking into 
account all tumor positions in the 4D dataset. In the first 6 patients, the PTV for treatment 
had been created using our previous protocol, prescribing the dose to >99% of the PTV, 
which required addition of a symmetric margin of 3 mm to the ITV [4]. Subsequently, a new 
protocol was implemented which required dose prescription to >95% of the PTV [19]. In 
order to achieve similar PTV doses as previously, the symmetric margin added was increased 
to 5 mm.  
 
Table 1: Details for 18 lung tumors investigated. 
Case 
ITV 
(cm3) 
PTV 
(cm3) 
Fractionation 
scheme Tumor Location 
1 17.0 30.8 5x11 Gy Right lower lobe adjacent chest wall 
2 33.1 60.1 8x7.5 Gy Right upper lobe (anterior)  
3 5.1 12.4 3x18 Gy Left lower lobe adjacent chest wall 
4 37.1 62.1 8x7.5 Gy Left upper lobe  
5 10.1 21.7 3x18 Gy Mid-central left lung 
6 2.1 6.3 3x18 Gy Mid-central right lung 
7 26.2 67.1 8x7.5 Gy Para-hilar left lung 
8 7.7 25.3 3x18 Gy Mid right lung adjacent to chest wall 
9 13.1 36.8 8x7.5 Gy Mid-posterior left lung 
10 2.1 11.9 3x18 Gy Right upper lobe adjacent to chest wall 
11 5.1 18.5 3x18 Gy Right upper lobe adjacent to chest wall 
12 19.0 43.9 5x11 Gy Right lung para-mediastinal 
13 28.7 32.8 5x11 Gy Left upper lobe  
14 5.2 18.3 3x18 Gy Right upper lobe 
15 7.5 27.8 3x18 Gy Mid-central adjacent to chest wall 
16 19.6 55.8 8x7.5 Gy Mid left lung adjacent to chest wall 
17 8.2 26.1 3x18 Gy Mid right lung adjacent to chest wall 
18 12.0 35.4 8x7.5 Gy Left upper lobe adjacent to chest wall 
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The average intensity projection CT dataset was used for dose calculation, and relevant 
OAR’s were delineated on this, including the contralateral lung, spinal cord, chest wall, 
oesophagus, heart, and trachea. The full thickness of the chest wall adjacent to the tumor was 
contoured for each patient, and this extended from the pleural for at least 2 cm in the 
direction of the skin.  
 
Planning technique 
All planning objectives for PTV and OAR were in accordance to those used in the ongoing 
ROSEL protocol [19], which required that 95% of the PTV receives at least the nominal 
fraction dose (this was 99% of the PTV for the first 6 patients), that 99% of the target volume 
receives ≥90% of the fraction dose, and that the maximum PTV dose is between 110% and 
140% of the prescription dose. The nominal fraction dose was prescribed to the 80% isodose. 
One out of 3 risk-adapted fractionation schemes was used (3 fractions of 18 Gy, 5 fractions of 
11 Gy, or 8 fractions of 7.5 Gy) for each case, as determined by T-stage and proximity to 
adjacent normal tissues [4].  
 
Details of clinical RapidArc planning are given below. For comparative purposes, two to 
three new plans were created per patient: standard non-coplanar 3D conformal SBRT plans 
(conf-SBRT), dynamic conformal arc plans (DCA) and IMRT for 9 patients with a PTV 
adjacent to the chest wall. Plans were generated using the Eclipse treatment planning system 
(version 8.2.23), based upon 6 MV photon beams from a Varian Clinac equipped with a 
Millennium Multileaf Collimator (MLC) with 120 leaves. All final dose calculations were 
performed with a grid resolution of 2.5 mm using the Anisotropic Analytical Algorithm 
(AAA) [20,21] taking into account heterogeneity correction. All RapidArc plans were 
delivered using a Varian Clinac Linear Accelerator using a maximum dose rate of 600 
MU/min. 
 
RapidArc  
RapidArc plans are based on a direct aperture optimization of the volumetric dose. It delivers 
the dose in a 358° gantry rotation, which consists of 177 control points. The optimizer of 
RapidArc can vary the MLC leaf positions, gantry rotation speed and dose rate at each 
control point. The optimization process proceeds through five multi-resolution levels and the 
number of control points is progressively increased at each level [12,16]. 
 
During the optimization process, the multi-resolution dose calculation (MRDC) algorithm is 
used for fast dose calculation. This algorithm is based on the 3D convolution of Monte-Carlo-
generated point-spread function kernels. When compared to the AAA-algorithm, which is 
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used for the final dose calculation [20], the MRDC does not accurately take into account the 
effects of tissue inhomogeneities. Similarly to the pencil beam algorithm, it lacks the 
accuracy to predict the lateral scatter of electrons in low density tissue. As a result, the dose 
volume histogram (DVH) in the optimizer shows a more homogenous dose coverage for the 
PTV than the plan would deliver in reality. AAA calculations of such plan show that the 
average PTV dose is lower than in the optimization and the dose at the borders of the PTV 
with interface to the lung can be much lower. Fig. 1 shows the comparison between the 
DVHs of a RapidArc plan for a small lung tumor as calculated by the optimizer (MRDC) at 
the end of the optimization, and as calculated by AAA.  
 
To compensate for dose differences between the MRDC and AAA, the PTV dose objective in 
the optimization is set 5-10% higher than that specified in the prescription. In order to 
overcome the problem of higher dose inhomogeneity, all plans consisted of at least 2 arcs, 
and results of the first optimized plan calculated with AAA is reduced to half of the 
prescribed dose and used as a ‘base dose’ plan. The optimization for the second arc uses the 
AAA calculated dose distribution of the first arc as a base dose that will be completed by the 
dose of the second arc. This second optimization compensates for any underdosage in the 
PTV from the first arc by giving extra doses to these areas as was described previously [13]. 
The final plan consists of the sum of the base dose plan and the second optimized plan.  
 
 
Fig. 1. DVHs comparison of the optimizer (left) and AAA calculation (right). The triangles represent dose-
volume objectives from the optimization. 
 
In addition to the specified optimization objectives, a 5 mm wide ring structure was 
constructed around the PTV as an additional OAR in order to ensure a rapid dose fall-off 
outside the PTV. For the chest wall, the dose was constrained according to the tumor 
Stereotactic radiotherapy for peripheral lung tumors:  A comparison of volumetric modulated arc therapy with 3 other delivery techniques 
________________________________________________________________________________________________________________ 
 33 
location. For the RapidArc treatments, planning objectives for the contralateral lung were 
only applied during clinical treatments for the last 9 patients.  
 
The clinical version of Eclipse used for treating the patients (version 8.2.23) of this study 
only allowed for a maximum of 999 MU to be delivered per arc. Hence, multiple arcs were 
required to deliver the prescribed fraction doses. Sequential gantry rotations in clockwise and 
counter-clockwise directions were used to minimize the time between the arc deliveries. 
Although Eclipse takes into account tongue-and-groove effects in its dose calculation, 
collimator angles of 40° and 45° were used for the 2 different arcs to minimize overlapping 
of this tongue-and-groove effect. 
 
3D conformal SBRT 
For each patient, several plans consisting of our previous standard treatment technique 
consisting of 10 static non-coplanar beams were derived [4]. Beam directions and weights 
were manually optimized according to the location of the tumor, mostly avoiding the 
contralateral lung. MLC settings were adapted manually to achieve the most conformal plans. 
Finally, an experienced radiation oncologist evaluated all plans generated for each patient, 
and then identified the best plan based upon OAR doses and/or clinical factors such as lung 
function or prior treatments.  
 
Dynamic Conformal Arc (DCA) 
DCA plans utilized a complete 360° gantry rotation with an isocenter located in the center of 
the tumor mass. The MLC settings of the field were adjusted dynamically according to the 
tumor outline for all gantry angles.  
 
IMRT 
In 9 cases where the PTV was adjacent to the chest wall, additional IMRT plans were 
generated with the key planning objective of reducing doses to the chest wall. IMRT plans 
generally consisted of 9-10 coplanar fields delivered using a sliding window technique. The 
beams were equally spaced through a 245º sector angle at the ipsilateral side of the lung, and 
optimization objectives were identical as for RapidArc optimization. Although the RapidArc 
optimizer differs from the IMRT optimizer, tests with several different optimization 
objectives showed that no further improvement in quality of plans could be obtained. Non-
coplanar beams were not evaluated in these IMRT plans due to concerns over excessively 
prolonged treatment delivery times. 
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Dosimetric analysis 
All plans were normalized such that prescription dose corresponded to the 80% isodose, and 
covered at least 95% of the PTV-volume (V80 = 95%). DVHs were analyzed, and the mean 
and maximum PTV doses were reported. Plan conformity was expressed using the 
Conformity Index, CI80%, CI60%, and CI40%. The conformity index of CI80 corresponds to ratio 
of the total body volume encompassed by 80% isodose line to the PTV volume receiving the 
same dose. The indices for CI60 and CI40 are similarly defined. 
 
For the esophagus, heart and trachea, the maximum dose received by 1 cm3 of each organ 
was recorded. The percentages of total lung minus PTV receiving 20 Gy (V20Gy) and 5 Gy 
(V5Gy) were recorded, although these are not commonly considered in stereotactic 
radiotherapy. The contralateral lung V5Gy values were noted. As reliable prospective data on 
correlation between dose and rib fractures are lacking [19], the volume of chest wall 
receiving 45 Gy or more (V45Gy) was arbitrarily chosen for plan comparison. In order to better 
compare the RapidArc and IMRT plans, the chest wall V30Gy and V20Gy were also analyzed. 
Finally, the number of Monitor Unit (MU) needed for each plan was collected to determine 
the dose-delivery efficiency of each technique. All data were averaged for the 18 patients, 
and dosimetric comparison between plans was performed using the Wilcoxon two-paired 
sample signed-ranks test. Differences were considered significant if P was <0.05. 
 
For RapidArc plans, the actual delivery time was recorded, excluding any time needed for 
additional imaging and set-up. For comparative purposes, similar delivery times for 12 
randomly selected stage I NSCLC patients treated with conf-SBRT with comparable dose 
schemes were retrieved from our clinical database. Delivery times for each IMRT plan was 
recorded by performing a ´dry run´ test on the Clinac Trilogy linear accelerator.  
 
Results 
 
DVH-analysis revealed that all plans created by the 4 techniques fulfilled the specified dose 
constraints. The dose statistics for each structure averaged over all 18 patients are 
summarized in Table II, and the same comparison between RapidArc and IMRT for 9 cases is 
summarized Table III. The errors indicate inter-patients variability at 1 standard deviation 
level.  
 
RapidArc plans achieved the best dose conformity, especially in regions of high dose (Fig. 2). 
When compared to conf-SBRT, DCA and IMRT plans, RapidArc reduced CI80% by 7%, 19% 
and 7%, and CI60% by 9%, 15%, and 6, respectively. In line with the improved conformity, 
Stereotactic radiotherapy for peripheral lung tumors:  A comparison of volumetric modulated arc therapy with 3 other delivery techniques 
________________________________________________________________________________________________________________ 
 35 
the chest wall V45Gy was also lowest with RapidArc (Fig. 2). For nearly all plans, lower chest 
wall V45Gy with RapidArc also corresponded to lower V30Gy and V20Gy compared to other 
techniques. 
 
Table 2: Summary of DVH-based analysis for PTV, OAR and monitor units generated in 18 patients. 
Organ Parameter RapidArc DCA conf-SBRT 
P-Value 
(RapidArc vs 
conf-SBRT) 
PTV Mean Dose relative 
to prescribed dose  (%) 114.8±4.0 114.2±2.8 113.7±3.9 
 
 
0.031 
PTV Max Dose relative 
to prescribed dose  (%) 133.8±7.1 129.1±7.0 131.7±9.0 
 
0.372 
CI80%  1.10±0.07 1.30±0.14 1.18±0.12 0.001 
CI60%  2.11±0.25 2.42±0.36 2.30±0.31 0.001 
CI40%  5.00±0.83 5.22±0.94 4.86±0.77 0.528 
Total Lung – PTV V20Gy(%) 5.4±3.2 5.4±3.3 4.9±2.9 0.025 
Total Lung – PTV V5Gy(%) 18.3±7.2 21.1±8.7 18.1±6.8 0.777 
Contralateral Lung, no 
optimization objective (9 
cases) V5Gy(%) 8.2±9.5 12.2±11.6 2.3±3.6 
 
 
0.028 
Contralateral Lung, with 
optimization objective (9 
cases) V5Gy(%) 4.4±4.0 11.9±9.9 1.2±1.8 
 
 
0.011 
Spinal Cord Dmax(Gy) 10.8±5.0 12.8±5.8 7.9±3.8 0.014 
Chest wall V45Gy(cm
3) 1.2±1.8 3.5±4.1 2.0±2.7 0.015 
MU Efficiency  MU/Gy 240±31 187±20 179±18 <0.001 
 
The higher dose conformity with RapidArc was associated with somewhat higher lung doses 
relatively to conf-SBRT, with the V20Gy for total lung minus PTV and V5Gy for contralateral 
lung increasing from 4.9% to 5.4%, and from 1.7% to 6.3%, respectively. 
 
The average delivery times for RapidArc plans were 10.5 min, 6.1 min, and 3.9 min for the 
18 Gy, 11 Gy, and 7.5 Gy fraction schemes, respectively. The mean delivery times for conf-
SBRT and IMRT were 11.6 and 12 min, respectively, and did not differ significantly for the 
different fractionation schemes.  
 
RapidArc plans generated larger number of MU compared to conf-SBRT and DCA. 
However, RapidArc achieved a reduction in the number of MU by the factor of 2 when 
compared to IMRT plans.  
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Table 3: Summary of DVH analysis for RapidArc versus IMRT in 9 patients with a PTV adjacent to chest wall. 
    RapidArc IMRT P-Value 
Organ  Parameter     
PTV Mean Dose   (%) 113.1±1.3 113.1±2.8 0.767 
PTV Max Dose   (%) 133.5±5.5 132.7±6.0 0.859 
CI 80%   1.07±0.02 1.14±0.06 0.008 
CI 60%   2.04±0.15 2.17±0.26 0.510 
CI 40%   4.78±0.65 5.38±1.10 0.008 
Lung  V20Gy(%) 4.4±2.7 4.2±2.5 0.374 
Lung  V5Gy(%) 17.0±7.7 14.7±6.9 0.110 
Contralateral Lung V5Gy(%) 3.0±4.4 1.2±1.7 0.128 
Chest Wall V45Gy(cm
3) 2.0±2.1 2.5±2.0 0.008 
  V30Gy(cm
3) 8.6±12.2 24.8±11.5 0.021 
  V20Gy(cm
3) 71.4±27.6 96.2±29.9 0.008 
MU Efficiency  MU/Gy 234±27 445±84 0.008 
 
 
 
Fig. 2. Case 11. Comparison of dose distribution in sagital planes. (a) RapidArc, (b) 10 beams conf-SBRT, (c) 
Dynamic Conformal Arc. The volume of the chest wall encompassed by the 30 Gy isodose was least for the 
RapidArc plan. 
 
Discussion 
 
The present study in 18 patients expands on our previous work in stage I lung tumors, and 
confirms that RapidArc permits much faster delivery of SBRT. In addition, RapidArc 
achieved superior plan conformity when compared to DCA, conf-SBRT and IMRT, 
particularly at the high dose regions. This allowed for better sparing of adjacent normal 
structures such as the chest wall. Although the differences in chest wall sparing at V45Gy were 
clinically modest due to the small target volumes, this dosimetric advantage can be more 
substantial when treating large lung tumors in the proximity of the chest wall [22].  In our 9 
patients with tumors adjacent to the chest wall, RapidArc plans achieved a significant 
reduction in V45Gy, V30Gy and V20Gy compared to other techniques. The lower chest wall V30Gy 
is likely to be of clinical significance as recent data suggests that V30Gy <30 cm
3 could reduce 
the risk of toxicity [23]. Due to the improved survival observed in populations after the 
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introduction of SBRT [24], attempts to minimize chest wall V30Gy may be important in long-
term survivors.  
 
Despite the requirement for more monitor units in RapidArc plans, treatment times were 
shorter than for conf-SBRT or IMRT, with delivery times ranging from 3.9 (7.5 Gy) to 10.5 
minutes (18 Gy per fraction) based on a maximum dose rate of 600 MU/minute. At present, 
our patients are treated on a Novalis Tx (Varian Medical Systems) using a dose rate of 1000 
MU/minute, which permits all patients to be treated with 2 arcs and in less than 6.5 minutes 
for the highest fraction dose. The faster delivery may further reduce the risk of intrafraction 
baseline shifts in tumor position which have been observed at treatment times exceeding 15 
minutes [10,11].  
 
A drawback of the present version of RapidArc is that planning for lung tumors is not 
straightforward due to differences between the dose calculation algorithm used in the 
optimizer and in final dose calculation. The requirement to create a base dose plan as a 
reference for optimization in the second arc, increases the planning time. A typical RapidArc 
optimization for a single arc required 10-15 min, followed by another 10 min for AAA dose 
calculations. For complex PTVs in the proximity of OAR, two or more optimization attempts 
are occasionally needed to achieve desired dose distributions. Therefore, planning time for a 
single lung case could be as short as 1 hour, extending to 3 hours if one or two re-
optimizations are necessary.  
 
The choice of appropriate planning constraints is important. RapidArc delivered dose over a 
larger body volume than conf-SBRT and IMRT, and the higher conformity was achieved at 
the cost of higher doses to the ipsilateral and contralateral lungs. The clinical relevance of 
higher doses to the ipsilateral and contralateral lung is unclear, although study of the 
relationship between SBRT dose and post-treatment CT density changes indicates a dose-
threshold effect in areas receiving more than 6 Gy [25]. 
 
Doses to the contralateral lung are now routinely reduced in clinical plans using partial arcs 
to avoid part of the contralateral lung, or by applying a higher priority for the optimization 
objective. In contrast to our findings, a recent planning study evaluating partial arc VMAT 
delivery for stage IA lung tumors reported better sparing of lung dose and in the CI50%, [26]. 
However, these authors did not specify the chest wall as an OAR. In contrast, our RapidArc 
plans were optimized to improve both dose conformity and chest wall sparing. As the use of 
partial arcs can reduce lung dose at the cost of compromised chest wall sparing, suitable 
optimization constraints must be adopted to obtained an appropriate sparing for both lung and 
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chest wall. For other OAR such as spinal cord, trachea, heart and esophagus, the doses were 
well under tolerance level for all 4 techniques and for most patients no further sparing was 
attempted in the RapidArc plans.  
 
The accuracy of IMRT delivery for mobile tumors has been a matter of concern [27]. Prior to 
any RapidArc SBRT delivery at our department, patient-specific dosimetry is routinely 
performed as part of the quality assurance procedure, and results show good agreement 
between calculations and measurement [28]. An extensive study of possible interplay effects 
between the MLC leaf motion and the tumor motion, using a moving phantom with motion 
up to 25 mm, revealed that the interplay effect for RapidArc lung SBRT is insignificant [29]. 
Apart from the reported maximum 3% dose difference, tumor motion causes dose blurring 
resulting in underdosage at the extreme positions of the PTV [30]. This is taken into account 
by using an ITV that encompass all tumor position in the breathing cycles. 
 
Conclusion 
 
The result of this planning study comparing different SBRT techniques for peripheral lung 
tumors measuring <70 cm3 confirms the ability of RapidArc to deliver highly conformal dose 
distributions. Despite the modest dosimetric gains in some cases, the superior speed of 
RapidArc delivery is a key consideration as it permits the highest doses of 18 Gy to be 
delivered in less than 6.5 minutes per fraction.   
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Abstract 
 
Purpose: To study the dosimetric predictors of early clinical toxicity following SBRT in 
patients with lung tumors and planning target volumes (PTV) exceeding 80 cm3.  
 
Methods: 18 consecutive patients who were treated using volumetric modulated arc therapy 
(RapidArc™) were assessed. All were either unfit or refused to undergo surgery or 
chemoradiotherapy. PTV planning objectives were as used in the ROSEL study protocol. 
Clinical toxicity was scored using Common Toxicity Criteria AE4.0. Lung volumes receiving 
5, 10, 15, and 20 Gy (V5, V10, V15 and V20) and mean lung dose were assessed and correlated 
to symptomatic radiation pneumonitis (RP). 
 
Results: Median age, age-adjusted Charlson-comorbidity score and PTV size were 74, 7.5 
and 137 cm3, respectively. At a median follow-up of 12.8 months, 8 deaths were recorded: 5 
arising from comorbidity, 2 were potentially treatment-related and 1 had local recurrence. RP 
was reported in 5 patients (grade 2 in 3 and grade 3 in 2).  All RP occurred in plans without a 
high priority optimization objective on contralateral lung. Acute RP was best predicted by 
contralateral lung V5 (p<0.0001).  
 
Conclusion: After SBRT using RapidArc in lung tumors >80 cm3, the contralateral lung V5 
best predicts RP. Limiting contralateral lung V5 to <26% may reduce acute toxicity.
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Introduction  
 
In patients with medically inoperable stage I non-small-cell lung cancer (NSCLC), better 
clinical outcomes are seen with stereotactic body radiotherapy (SBRT) as compared to 
conventional fractionated radiotherapy [1]. Reported local control rates range from 88–92% 
although most studies report only outcomes for small tumors: nearly 90% of patients treated 
in some series had planning target volumes (PTV) smaller than 70 cm3 [2—4]. In contrast, 
local failure rates are higher in patients undergoing SBRT for lesions larger than 3 cm (T2) 
lesions [1].  In addition, lung tumors measuring 5 cm or larger also show a high incidence of 
distant failures, even after a complete surgical resection [5]. The high incidence of distant 
failure provides a rationale for our standard approach for treating patients with tumors >6 cm 
who are unfit to undergo surgery with concurrent chemoradiotherapy using conventional 
fractionation schemes.  
  
Until 2008, SBRT for mobile tumors measuring >6 cm with SBRT was not technically 
possible at our center due to field size restriction on our designated linear accelerator 
(LINAC) [4]. In 2009, RapidArcTM (Varian Medical Systems, Palo Alto, CA) become our 
standard approach for SBRT of lung tumors as it allowed for plans with higher conformity, 
reduced chest wall doses and permitted faster SBRT delivery [6]. In patients with tumors >6 
cm who were unfit to undergo surgery or chemoradiotherapy, or who refused conventional 
chemoradiotherapy, we implemented SBRT on newer linear accelerators as the prognosis 
using conventional radiotherapy alone was dismal.  
 
However, the toxicity related to SBRT for larger tumors is not well described yet. In general, 
SBRT-related toxicity includes radiation pneumonitis (RP), bronchial stenosis or necrosis, 
esophageal injury, rib fractures and injuries to the brachial plexus [1]. Parameters shown to 
correlate with RP after conventional radiotherapy include lung volume receiving 5 Gy, 10 
Gy, 13 Gy, 20 Gy and 30 Gy or mean lung dose (MLD) [7-10]. RP is uncommon after SBRT, 
but early reports suggested that tolerance values of 50% probability of lung toxic events are 
mean lung dose (MLD) of 1.2 Gy, and V7 (volume of lung receiving 7 Gy or more) and V10 
values of 5.8% and 3.1% respectively [11]. The goal of this study was to evaluate the relevant 
dosimetric parameters and early clinical toxicity in patients with planning target volumes 
(PTVs) >80 cm3 treated with SBRT. 
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Materials and methods 
 
Eighteen consecutive patients with stage I-II lung tumors without nodal metastases who had 
completed SBRT using RapidArc at the VU University Medical Center (VUmc) prior to 
December 31, 2009, and whose PTV was 80 cm3 or more were analyzed. Patients with 
synchronous non-pulmonary malignancies were excluded. Prior to referral for SBRT, patients 
were discussed in multi-disciplinary tumors board which included pulmonary oncologists and 
surgeons.  
 
Patients were ineligible for surgical treatment or concurrent chemoradiotherapy due to 
comorbidities or patient refusal. SBRT for all patients was delivered as part of a routine 
clinical care within departmental protocols. All patients had solitary primary tumors and 
more than 3 months follow-up.  
 
Details of our protocol for imaging and target definition have been described previously [6]. 
Briefly, patients were imaged and treated during uncoached quiet respiration. A single four-
dimensional computed tomography scan 4DCT (GE Medical Systems, Waukesha, USA) was 
performed with the patient in a supine position with both arms above the head using an arm 
rest. No other fixation or immobilization device was used. The images were reconstructed in 
ten equally spaced time bins of 2.5 mm slice thickness using respiratory phase binning [12]. 
An internal target volume (ITV) was delineated, accounting for all tumor positions in the 
4DCT dataset. The PTV was obtained by uniformly expending the ITV with a 5 mm margin.  
 
The average intensity projection CT dataset was used for dose calculation and the contouring 
of all relevant organs at risk (OAR) such as the contralateral lung, spinal cord, chest wall, 
oesophagus, heart, and trachea. The chest wall adjacent to the tumor was contoured for each 
patient by including a volume of least 2 cm thickness extending from the pleura surface.  
 
RapidArc plans were generated in the Eclipse treatment planning system, using a 6 MV 
photon beam. The first 7 patients were planned using Eclipse version 8.2.23, before a 
software upgrade to version 8.6.15 which permitted the use of an avoidance sector, i.e. 
defining a section of the arc without radiation delivery.  The first two patients were treated on 
a Varian Trilogy accelerator equipped with a Millenium Multileaf Collimator (spatial 
resolution of 5 mm at isocenter) at a maximum dose rate of 600 MU/min. All other patients 
were treated on a Varian Novalis Tx accelerator equipped with a high definition Multileaf 
Collimator (spatial resolution of 2.5 mm at isocenter) at a maximum dose rate of 1000 
MU/min. The collimator angles of all plans were set to 40° or 45°. 
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The planning objectives for the PTV were in accordance to those used in the ongoing ROSEL 
protocol which required that 95% of the PTV receives at least the nominal fraction dose, that 
99% of the target volume receives ≥90% of the prescription dose, and that the maximum PTV 
dose is between 110% and 140% of the prescription dose [13]. Risk-adapted fractionation 
schemes of either 5 fractions of 11 Gy or 8 fractions of 7.5 Gy were used, depending on T 
stage and estimated risk of normal tissue toxicity [4]. All plans were normalized such that the 
nominal fraction dose corresponded to the 80% isodose. Dose was calculated using the 
Anisotropic Analytical Algorithm (AAA), accounting for tissue inhomogeneity, with a 
standard grid resolution of 2.5 mm [14]. 
   
All plans were delivered using at least 2 arcs for each fraction. During the optimization, the 2 
different arcs plans were optimized sequentially, where the second arc refers to the dose 
distribution of the first calculated arc plan and compensates for any underdosage area in the 
PTV [15]. The final plan consisted of both the base dose plan and the second optimized plan. 
Sequential gantry rotations in clockwise and counter-clockwise directions were used to 
minimize the time between the arc deliveries. Treatment delivery was generally completed in 
less than 7 minutes [6].  
 
Chest wall and mediastinum optimization objectives were individually set according to tumor 
location.  When the PTV invaded any of the above OAR, upper optimization objectives limits 
were set to 80-90% of the prescription dose with high priority in order to ensure a rapid dose 
falloff at the PTV-OAR interface. For the first 5 patients, no optimization objective was 
applied to reduce the dose to the contralateral lung. With growing experience in planning 
such tumors, high priority optimization objectives were used for contralateral lung, often in 
combination with use of an avoidance sector or partial rotation arc, for the next 13 patients 
treated. For the other OAR such as trachea, esophagus, spinal cord, plexus, and heart, 
optimization objectives were applied if the OAR were in close proximity to the PTV in order 
to keep the final dose below values recommended in the ROSEL study.  A 5 mm wide ring 
structure around the PTV was used as an additional OAR to ensure a rapid dose fall-off 
outside the PTV.  
 
Patients treated on the Novalis Tx LINAC were set up using the Exactrac X-Ray 6D 
(BrainLAB, Heimstetten, Germany). During each treatment fraction, the patients were 
initially positioned using the infrared reflective markers of the ExacTrac system [16]. A cone-
beam computed tomography (CBCT) scan was performed with the kilovoltage onboard 
imaging system, OBI (Varian Medical System, Palo Alto, CA). The images from CBCT scan 
were subsequently registered with the planning CT scan using the automatic soft-tissue match 
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at the region of PTV plus 1 cm margin and were verified, and if necessary adapted, prior to 
treatment. The resulting discrepancies were corrected by the remote-controlled couch shift in 
all three directions, and couch rotation.   
 
Routine clinical follow-up was performed every 3 months after treatment, with a diagnostic 
CT scan done at each visit. In frail patients who were unable to attend routine follow-up at 
our center, planned three monthly follow-up was performed by telephone, combined with 
information from the lung physicians or primary care providers. Clinical pneumonitis was 
assessed using the Common Terminology Criteria for Adverse Events, version 4.0 [17]. For 
any patients with incomplete follow-up data, hospital records were obtained and general 
practitioners were contacted to provide missing information. 
 
Dosimetric data was abstracted from the planning system, and the mean and maximum PTV 
doses were reported. Plan conformity was expressed using the Conformity Index (CI). The 
CI80 corresponds to ratio of the total volume encompassed by 80% isodose line and the PTV 
volume receiving the same dose. The indices for CI60 and CI40 are similarly defined. 
 
All reported lung doses refer to the volume of lung excluding the PTV. Mean lung dose 
(MLD), V5 (volume of “lung minus PTV” receiving 5 Gy or more), V10, V15, and V20 were 
assessed separately for the total lung, ipsilateral and contralateral lungs. For esophagus, heart 
and trachea, the maximum dose received by 1 cm3 (D1cm
3) of the organ was recorded. For the 
chest wall, V45, V30, and V20 and the maximum dose to 2 cm
3 (D2cm
3) were assessed.  
 
All statistical tests were two-sided with p≤0.05 indicative of statistical significance, and all 
statistical analyses were performed using the Statistical Package of Social Sciences (SPSS 
version 15.0, Chicago, USA) 
 
Results 
 
Fourteen patients had chronic obstructive airway disease (six having Global Initiative for 
Chronic Obstructive Lung Disease [GOLD] scores III or IV), 13 had cardiovascular diseases 
(including severe coronary artery disease, impaired cardiac function, peripheral vascular 
disease, or previous cerebrovascular events), two had renal failure, and one had undergone 
prior resection of 3 lung lobes for lung cancer. The median age-adjusted Charlson score was 
7.5 (range 5-10). The median World Health Organization (WHO) performance score was 2 
(range 1-3). Representative axial images from the first 9 patients are shown in Fig 1. The 
mean PTV volume was 137 cm3 (range 87-286 cm3).  Median treatment duration was 14 days 
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(range 10-20 days). All patients tolerated the treatment and completed it uneventfully. The 
median follow-up after treatment was 12.8 months, determined using the reverse Kaplan-
Meier method [18].  Clinical characteristics are summarized in Table 1.  
 
 
Fig. 1. Illustrative pre-treatment CT images for the first nine consecutive patients with large tumors (PTV 
indicated by an arrow). 
 
Causes of death were obtained from hospital records, attending physicians, and family 
physicians. Two deaths were potentially treatment-related: a 65-year old man died of 
respiratory insufficiency associated with hemoptysis. Another death involved a 64-year old 
lady whose grade 3 RP responded poorly to steroid, and who subsequently requested 
euthanasia (Patient 4 in Fig. 1). Finally, an 84-year old man with pathologically confirmed 
local recurrence subsequently died of a pulmonary hemorrhage 10 months after SBRT 
(Patient 1 in Fig. 1). Five patients died of causes deemed unrelated to treatment: cerebral 
hemorrhage (n=1), complications of peripheral vascular disease (n=1), renal and heart failure 
(n=1), myocardial infarction in a patient whose tumors was not in the proximity of the heart 
(n=1), and collapse presumed to be of cardiac origin (n=1). Most deaths occurred in patients 
of age 80 or greater: five of seven patients in this age group died during the follow-up period. 
 
The dose statistics for each structure averaged over all 18 patients are summarized in Table 2. 
The dose-volume histogram (DVH) analysis revealed that most plans fulfilled the acceptance 
criteria of the ROSEL randomized trial, although these constraints could not be met in all 
cases due to the large tumor sizes. For example, in a few cases, with PTV adjacent to the 
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trachea or oesophagus, the dose-volume constraints recommended by the ROSEL study were 
not achieved.  
 
Table 1: Clinical and treatment characteristics for 18 patients with large stage I NSCLC tumors planned for 
stereotactic lung radiotherapy using RapidArc.  
 
 
Five patients (28%) developed RP: 3 had grade 2 pneumonitis and 2 had grade 3 
pneumonitis. These five patients with RP were the first five in this study group, and all were 
planned without avoidance sector or optimization objective on the contralateral lung. One 
patient developed grade 2 esophagitis, and one patient with a large anterior tumor developed 
grade 2 edema of the breast and anterior chest wall (Fig. 2), both of which resolved with 
further follow-up. Two patients had grade 2 thoracic wall pain. 
Variable Median (range) or No. (%) 
Age  74 (60-91) 
Gender   
   Female 6 (33%) 
   Male 12 (67%) 
FEV1 (Forced expiratory volume in 1 second) 1.46 L (0.71-2.80 L) 
History of previous smoking 18 (100%) 
Pathological confirmation (malign. or abn. cells) 12 (67%)  
ITV volume  75 cc (40-165 cm3) 
PTV volume  137 cc (87-286 cm3) 
Major organs at risk (most patients had >1)  
   Chest wall 14 (78%) 
   Spinal cord and vertebrae 7 (39%) 
   Esophagus 7 (39%) 
   Brachial plexus 3 (17%) 
   Ipsilateral pacemaker 3 (17%) 
   Other mediastinum including heart 11 (62%) 
Tumor location   
   Central (≤ 2 cm from mediastinum) 13 (72%) 
   Peripheral 5 (28%) 
   Upper (above carina) 8 (44%) 
   Lower 10 (56%) 
Dose and Fractionation  
   5 x 11 Gy  8 (44%) 
   8 x 7.5 Gy 10 (56%) 
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Fig. 2. Grade 2 edema of the anterior chest wall and breast in a patient with a paramediastinal lung tumor treated 
with stereotactic radiation therapy. Left: radiotherapy plan, with planning target volume outlined in red and dose 
scale at left. Left: CT scan six months after treatment showing edema of the left breast and pectoralis. 
 
Table 2: Summary of DVH-based analysis for PTV and OAR for 18 patients. 
Organs Parameter Average (Range) 
PTV mean Dose relative to prescribed dose (%) 113 (110-119) 
PTV max Dose relative to prescribed dose (%) 132 (122 – 140) 
Max dose at 2cm (Gy) 41 (22 – 49) 
CI 80%  1.08 (1.03 – 1.15) 
CI 60%  1.84 (1.68 – 2.06) 
CI 40%  3.92 (3.27 – 4.55) 
Total Lung – PTV V20Gy (%) 10 (2 – 18) 
  V15Gy (%) 13 (3 – 21) 
 V10Gy (%) 19 (6 – 42) 
  V5Gy (%) 31 (15 – 59) 
Ipsilateral Lung – PTV V5Gy (%) 44 (15 – 65) 
Contralateral Lung V5Gy (%) 19 (0 – 51) 
Spinal Cord, max dose Dmax (Gy) 16 (7 – 28) 
Chest Wall V45Gy (cm
3) 31 (0 – 88) 
  V30Gy (cm
3) 117 (0 – 238) 
  V20Gy (cm
3) 222 (3 – 384) 
  D2cm
3 (Gy) 56 (20 – 73) 
*Esophagus, 1cc D1cm
3 (Gy) 20 (9 – 36) 
Trachea, 1cc D1cm
3 (Gy) 19 (0 – 68) 
* Average for only 12 patients with PTV in close proximity to Esophagus 
 
Fig. 3 shows the relationship between lung dose parameters and RP. Total lung V5 and 
contralateral lung V5 were the best predictors of RP, as all patients with total lung V5>37% or 
contralateral lung V5>26% developed pneumonitis, whereas none of the patients below these 
thresholds developed symptoms. Correlations with clinical symptoms were very strong and 
highly significant for both these variables (r>0.85, p<0.0001 for both). Ipsilateral lung V5 
correlated less strongly with clinical symptoms (r=0.66, p=0.004), as did mean lung dose 
(r=0.71, p=0.004) and total lung V10 (r=0.58, p=0.01). Total lung V15 and V20 did not 
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correlate with symptomatic pneumonitis (r<0.4, p>0.1 for both). PTV size also correlated 
with symptomatic pneumonitis (r=0.55 p=0.02). 
 
The total lung V5, V10, V15, V20 were all inter-correlated (all r>0.6, and p<0.01), yet 
contralateral lung V5 did not correlate significantly with ipsilateral V5 or total lung V10, V15, 
or V20, (all r<0.5 and p>0.05), suggesting that some alterations in contralateral lung V5 may 
be achieved without substantially affecting the other dosimetric variables.  
 
 
Fig. 3. Relationship between dosimetric lung parameters and development of symptomatic radiation 
pneumonitis. VX = volume of lung (%) receiving >X Gy; MLD: mean lung dose (Gy). 
 
Discussion 
 
Our study of early clinical toxicity after SBRT using RapidArc for lung tumors > 80 cm3 
reveals that the contralateral lung V5, total lung V10 and V5, MLD and the PTV size were all 
correlated with RP. The best correlation was observed for contralateral lung V5, with all 
patients with a contralateral lung V5>26% developing RP. Compared to our previous reports 
on post-SBRT lung treatments [4], this population of patients with larger tumors showed a 
higher rate of RP (28% vs. <10% in previous reports), a finding probably due to the larger 
size of the PTV treated in the current study. In addition, RP was highly influenced by the 
planning technique. 
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Unlike conventional radiotherapy, the unique fractionation schemes and dose distribution of 
SBRT have established a very distinctive clinical toxicity pattern [19]. Conversely, reliable 
dose-volume metrics as predictors for RP are lacking [20].  
 
Previous studies on correlations between radiation pneumonitis (RP) and dosimetric 
parameters have occasionally shown conflicting findings. Although Fujino et al found no 
significant correlation between dosimetric factors and post-SBRT RP requiring steroids, 
doses lower than 20 Gy were not analyzed [21]. Takeda et. al. analyzed 128 patients with 
lung tumors post-SBRT and found no pretreatment clinical or dosimetric factors to be 
associated with RP grade ≥ 3 [22]. However, patients with RP grade 2 were excluded from 
their study. Yamashita et al reported RP grade ≥ 2 in seven of 25 patients after SBRT and 
reported that only the plan conformity index was significantly associated with the risk of RP, 
but other lung dose-volume metrics showed no significant correlation [23].  
 
Several studies suggested that the mean lung dose (MLD) can predict for RP grade ≥ 2. 
Guckenberger et. al. analyzed 59 patients treated with SBRT for primary NSCLC and 
pulmonary metastases and reported that the MLD calculated for ipsilateral lung was the only 
factor significantly correlating with RP [24]. Similarly, Borst et al reported similar findings 
using MLD calculated over total lung volume excluding gross tumor volume [25]. However, 
doses to the contralateral lung alone were not analyzed in any of above mentioned studies.   
 
The median size of PTVs investigated in our study was larger than those reported in similar 
studies (137 cm3 vs. < 45 cm3) [11, 21-25]. A study of lung density changes on follow-up CT 
scans of 50 patients post-SBRT revealed increases in Hounsfield Unit in areas receiving more 
than 6 Gy [26], which was greater in patients with large PTVs. 
 
Our findings indicate that MLD had weaker correlation with RP, as well as V10. Total lung 
and contralateral lung V5 appeared to be the best predictors in which all patients with total 
lung V5>37% and contralateral lung V5>26% developed pneumonitis. Contralateral lung V5 
did not correlate significantly to any ipsilateral lung variables, suggesting that contralateral 
lung V5 alone could predict the risk of RP instead of total lung V5. This finding agrees with a 
current report suggesting that contralateral lung V5 as an independent predictor for the 
development of ≥grade 3 RP for patients with stage III lung tumors treated with conventional 
fractionation [27]. This correlation between contralateral lung dose and risk of RP can be 
explained by the possible functional compensatory changes in the contralateral lung due to 
ipsilateral lung radiation-induced injury [28]. As a result, sparing the contralateral lung may 
reduce the risk of RP.  
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Shorter treatment times for RapidArc have the advantage of reducing the likelihood of intra-
fraction tumors displacements [29]. However, a trade-off of all forms of volumetric 
modulated arc therapies is that the low-dose regions are larger and more commonly involve 
the contralateral lung [6, 30]. The first five patients in this study group were planning without 
the use of avoidance sector, partial rotation arc or high priority optimization objective to limit 
the dose to contralateral lung and as a result, all had contralateral lung V5 >26%. 
Subsequently, all these patients developed RP. Reassuringly, implementing an avoidance 
sector or high priority optimization objective on the contralateral lung effectively reduced the 
dose to the contralateral lung and led to no further cases of RP. 
 
Limiting beams coming from contralateral direction by using avoidance sectors or partial 
rotation arcs can also be beneficial for the sparing of the mediastinal organs but a drawback is 
expected to be an increase in dose to the chest wall. Reported parameters for chest wall 
toxicity and radiation-induced rib fracture after SBRT are volume receiving ≥30Gy [31] or 
dose to 2 cm3 of the chest wall [32]. The latter publication suggested the correlation between 
D2cm
3 and the probability of rib fracture, with the 5% and 50% risks given by total dose of 
27.3 Gy and 49.8 Gy, respectively. By fitting our data with the adjustment for the biological 
effective dose for different fractionations, more than 80% of the patients had the likelihood of 
>5% risk of developing ribs fracture, and one patient was found to have >50% risk of 
developing ribs fracture. During our follow up, 2 patients had grade 2 chest wall pain but no 
ribs fracture has been reported. However, due to the limited follow up period and high 
involvement of the chest wall in the treatment field, more chest wall toxicity may be expected 
over time. Sparing of the chest wall remains a challenge during the optimization. For the 
patient who developed edema of the breast and anterior chest wall, the V45 was the highest of 
all patients reported herein, but not the V30 nor V20, reinforcing the importance of reducing 
high dose area outside the PTV.   
 
Although our follow-up data were complete, a key limitation of our study is the short follow-
up time of all patients, a finding that is reflective of the frail patients who were referred from 
other regions for treatment. The extensive non-cancer related co-morbidity profile of our 
patients, as reflected by the median age-adjusted Charlson score of 7.5, makes this population 
unsuited for studying late SBRT toxicity. However, a median follow up of 12.8 months 
deemed to be sufficient for the detection of clinical RP as previous studies have demonstrated 
that RP generally manifests at a median interval of 5 months post-SBRT [23-24]. The 
majority (72%) of our patients had major cardiac co-morbidity, which in itself carries a poor 
prognosis: when patients present with heart failure as a primary diagnosis, the 5-year all 
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cause survival is only 24.4% [33]. Consequently, non-cancer mortality can mask the 
incidence of other subacute and late toxicity, which in turn raises the issue as to whether 
SBRT should be offered to unfit patients with larger stage I tumors when predictors of 
toxicity are not well established. Our routine protocols accept such patients for treatment, 
since untreated stage I NSCLC is associated with 1- and a 5-year survival of 49% and 4% 
respectively [34]. Furthermore, the alternative treatment of primary surgery in patients with 
severe COPD is associated with an in-hospital mortality ranging from 8-14% and local 
recurrence rate of 20-26% [35]. In view of the above findings, our routine protocols have 
consistently accepted such high-risk patients and previous analysis revealed only modest 
early toxicity when central tumors measuring ≤6 cm were treated dose fractions of 7.5-11 Gy 
[36]. 
 
Early clinical toxicity patterns observed in this study highlight the importance of the 
optimization technique in order to reduce RP. Longer follow up may assist the process of 
treatment planning and hopefully to establish an acceptable dose-volume limit for each OAR. 
 
Conclusion 
 
SBRT using RapidArc is feasible for patient with stage I lung tumors ≥ 80cm3. Our results 
suggest that contralateral lung V5 is strongly correlated to RP and should be kept lower than 
26%. We observed a higher risk of RP than previous studies, but the use of avoidance sectors 
and high priority optimization objectives can effectively limit the dose to the contralateral 
lung, thus, reducing the risk of RP.  In the future, it is crucial to further characterize the 
dosimetric and clinical trade-offs in choosing an acceptable dose for each OAR (e.g. 
contralateral lung, mediastinal organs or chest) to create optimal treatment plans for patients 
with large tumors.  
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Abstract 
 
Purpose: Volumetric modulated arc therapy (RapidArc™) allows fast delivery of stereotactic 
radiotherapy (SBRT) for stage I lung tumors. We investigated discrepancies between the 
calculated and delivered dose distributions, and the dosimetric impact of leaf interplay with 
breathing-induced tumor motion.  
 
Methods and Materials: In 20 consecutive patients with stage I lung cancer who completed 
RapidArc delivery, 15 had tumor motion exceeding 5mm on 4D CT-scan. Static and dynamic 
measurements were performed using Gafchromic EBT film in a Quasar™ motion phantom 
(Modus Medical Devices Inc.). Static measurements were compared with calculated dose 
distributions, and dynamic measurements were compared with the convolution of static 
measurements with sinusoidal motion patterns. Besides clinical treatment plans, additional 
cases were optimized to create excessive MLC modulation and delivered on the phantom 
with peak-to-peak motions up to 25 mm. Gamma analysis with 3% dose difference and 2 mm 
or 1 mm distance to agreement was used to evaluate accuracy of delivery and dosimetric 
impact of interplay effect.  
 
Results: In static mode, film dosimetry of the 2-arc delivery in the phantom showed that on 
average, <3% of measurements had gamma>1. Dynamic measurements of clinical plans 
showed high degree of agreement with the convolutions: for double arc plans, 99.5% met the 
gamma criterion. This was 98.5% for the plans with excessive MLC modulations and 25 mm 
motion.  
 
Conclusion: Film dosimetry reveals that RapidArc accurately delivers the calculated dose 
distribution, and that interplay between leaves and tumor motion is not significant for single 
fraction treatments, when RapidArc is delivered with two different arcs.
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Introduction 
Stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancers has been 
shown in a meta-analysis to result in superior local control rates than with conventionally 
fractionated radiotherapy [1]. We have reported local control rates exceeding 90% using 10 – 
12 static non-coplanar beams and risk-adapted fractionation schemes [2], and other groups 
have reported local control rates ranging from 88% to 92% [3, 4].  As SBRT is increasingly 
being evaluated in fitter patients who have a lower likelihood of non-cancer related mortality 
[5], the use of improved techniques that can reduce the risk of late toxicity after SBRT 
becomes more important. 
 
RapidArc™ (Varian Medical Systems, Palo Alto) is a volumetric modulated arc therapy 
technique which delivers the dose in one or more gantry rotations with variable MLC 
positions, dose rates and gantry speed [6]. RapidArc can achieve treatment plans quality 
which is at least comparable to those generated with conventional intensity modulated 
radiotherapy (IMRT), but with a substantial reduction in treatment time and a high precision 
of dose delivery [7-10]. Moreover, a study in patients with stage I lung cancer revealed that 
RapidArc SBRT can achieve better target dose conformity than when a conventional 10-field 
non-coplanar approach was used [11]. However, a key concern with IMRT delivery in mobile 
tumors is the possibility of interplay between tumor motion and multileaf collimator (MLC) 
motion. Such interplay effect can cause hot/cold spots of dose within the target volume, and 
the resulting dose can vary up to 18% in a single fraction [12]. Significant dose discrepancies 
of up to 29% have also been reported from the presence of longitudinal tumor motion during 
helical tomotherapy [13]. It has been suggested that the interplay effect may have only a 
small dosimetric impact if treatments are delivered in 30 fractions, as the observed dose 
variations then decreased to 1 – 2% [14]. However, this finding might not be applicable in 
RapidArc lung SBRT delivery which generally completed in 3 – 8 fractions. 
 
RapidArc treatments commenced at our Department in May 2008, and all plans are verified 
with film or ionization chamber array prior to the treatment. For SBRT using RapidArc, the 
quality assurance (QA) procedures were performed using film measurements in different 
phantoms. The aim of the present study was to evaluate the dosimetric accuracy between the 
delivered and calculated dose distributions for lung treatment, and the possible interplay 
between MLC motion and tumor motion. This interplay effect for RapidArc was investigated 
by measuring the RapidArc delivered dose distributions in a respiratory motion phantom 
capable of performing a programmable motion pattern.  
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Materials and methods 
 
All data from the first 20 patients treated with RapidArc for stage I lung cancer were 
analyzed. All had undergone a four-dimensional (4D) CT-scan as reported previously [15]. 
An internal target volume (ITV) which encompassed all motion was delineated, and a 
planning target volume (PTV) created by adding a margin of 3-5 mm to the ITV. The 
amplitude of tumor motion for each patient was accessed by measuring the peak to peak 
tumor position from different phases of breathing cycle on an Advantage 4D workstation (GE 
Healthcare, United Kingdom). Tumor characteristics are summarized in Table 1. The mean 
PTV was 53.4 cm3. 17 patients had a PTV ranging from 6.3 cm3 to 83.4 cm3, and tumor 
motion exceeded 5 mm in 12 patients. Three patients had large PTV volume (range 141.1 to 
198.1 cm3) and tumor motion larger than 15 mm. Patients were treated with one of the 3 risk 
adapted fractionation schemes: 3 fractions of 18 Gy, 5 fractions of 11 Gy, or 8 fractions of 
7.5 Gy, and all plans were normalized such that the prescription dose corresponded to the 
80% isodose [2].  
 
Table 1: Details of the 20 lung tumors investigated 
Case 
PTV 
(cm3) 
Fractionation 
scheme MU 
Maximum cranio-caudal 
Motion (mm) Tumor Location 
1 6.3 3 x 18Gy 5845 10 Mid-central right lung 
2 11.9 3 x 18Gy 4343 8 
Right upper lobe adjacent to chest 
wall 
3 12.4 3 x 18Gy 3882 10 
Left lower lobe (Inferior-medial 
adjacent chest wall) 
4 18.3 3 x 18Gy 3856 8 Right upper lobe 
5 25.3 3 x 18Gy 3740 25 
Mid-posterior right lung adjacent 
chest wall 
6 27.8 3 x 18Gy 3460 6 Mid-central adjacent to chest wall 
7 29.7 3 x 18Gy 3414 0 Left upper lobe adjacent to chest wall 
8 30.8 5 x 11Gy 2217 13 Right lower lobe adjacent chest wall 
9 32.8 5 x 11Gy 2467 0 Left upper lobe 
10 36.8 8 x 7.5Gy 1779 11 Mid-posterior left lung 
11 41.4 8 x 7.5Gy 1689 8 
Right upper lobe adjacent to chest 
wall 
12 43.9 5 x 11Gy 2434 0 Right lung para-mediastinal 
13 50.4 5 x 11Gy 2222 0 Superior right lung adjacent chest wall 
14 55.8 8 x 7.5Gy 1913 9 Mid-posterior right lung 
15 67.1 8 x 7.5Gy 1735 0 Para-hilar left lung 
16 75.8 8 x 7.5Gy 1893 5 Right upper lobe 
17 83.4 5 x 11Gy 2226 8 Left upper lobe adjacent to chest wall 
18 141.1 5 x 11Gy 2455 20 Right lower lobe adjacent chest wall 
19 170.2 8 x 7.5Gy 1666 15 Mid-posterior left lung 
20 198.1 8 x 7.5Gy 1937 20 Right lower lobe 
Abbreviations: PTV = planning target volume; MU = monitor units 
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Planning and Calculations  
RapidArc plans were created using the Eclipse treatment planning system (version 8.2.23, 
Varian Medical Systems). Most plans were generated and delivered based upon 6 MV photon 
beams from a Varian Trilogy accelerator equipped with a Millennium Multileaf Collimator 
(MLC) (spatial resolution of 5 mm at isocenter). Eight patients were treated with 6 MV 
photon beams on a Novalis TX accelerator equipped with a high definition MLC (spatial 
resolution of 2.5 mm at isocenter). The collimator angles for all delivered arcs were set at 40° 
or 45°. 
 
Planning objectives for PTV and OAR were in accordance with specifications in an ongoing 
phase III study protocol [5]. Two-arc optimization was routinely used where the results of the 
first optimized plan calculated with the Eclipse AAA algorithm for half of the prescribed 
dose was used as a ‘base dose’ plan for optimizing the second arc, as described previously 
[7]. The second optimization compensates for any underdosage in the PTV in the base dose 
plan arising from lack of electronic equilibrium at lung-tissue interfaces that was not 
accounted in the optimization algorithm by giving more doses to these areas. The final plan 
consisted of the sum of the base dose plan and the second optimized plan. Depending on the 
fractionation scheme, each SBRT fraction used between 2 to 6 arcs per fraction as the initial 
clinical version of RapidArc delivery only allowed for a maximum of 999 monitor unit (MU) 
to be delivered per arc.  
 
The total number of MU generated for each fraction ranged from 1689 MU to 5845 MU, 
depending on the prescribed dose. The plans required different amounts of MLC modulation, 
with plans for tumors in close proximity to the chest wall or mediastinum generally requiring 
the most MLC modulation. In order to avoid extreme MLC modulation, a MU-objective was 
set as an upper constraint during the optimization for the clinical plans. 
  
For 1 patient with 25 mm tumor motion (case 5) and 2 randomly selected patients (case 12  
and 14), extra plans were created specifically for the purpose of this present study in order to 
evaluate possible interplay effects between the leaf motion and tumor motion. These plans 
were optimized using more extreme planning objectives, and a minimum MU objective in 
order to generate plans with excessive MLC motions, smaller effective field sizes, and 
consequently, more monitor units. In theory, the increased MLC leaf modulation in 
combination with smaller effective MLC opening can be more susceptible to interplay 
effects.  These plans were not commonly seen in our clinical cases due to fact that the extra 
monitor units will prolong the delivery time, and as dosimetry were not significantly better. 
Hence, only 3 cases were investigated for the interest of this study.  
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The dose distribution of each arc was recalculated on a static CT-scan of the Quasar Phantom 
(Modus Medical Devices Inc., London, ON, Canada). The Quasar Phantom (Fig. 1) contained 
a cylindrical lung insert, made of low-density cedar (0.4 g/cm3). Inside are two polystyrene 
spheres (1.05 g/cm3) with diameters of 15 and 30 mm representing the tumors. The sphere 
with a size closest to the diameter of the ITV of the patient was used for the measurement. 
The isocenter was positioned such that the high dose was delivered around the spherical 
insert. The lung insert can perform a cyclic movement in the longitudinal direction with user 
specified amplitude and movement pattern. The movement, simulating the respiratory 
motion, was set as sinusoidal pattern with a period of 5 seconds per cycle, and the amplitude 
of the tumor movement was derived from the 4DCT scan of each patient. The delivery of 
each arc was started randomly during the breathing cycle. The total number of breathing 
cycles during one arc was between 16 and 20.  
 
 
Figure 1. CT images of the Quasar phantom in transverse plane (left) and coronal plane (right).  
 
All dose calculations were performed with a grid resolution of 2.5 mm using the Eclipse 
Anisotropic Analytical Algorithm, taking into account heterogeneity correction.  
 
Dose measurement 
Prior to RapidArc treatment delivery, patient-specific dosimetry with the Quasar phantom 
was routinely performed as part of the QA procedure. Static measurements were performed in 
all cases, but dynamic measurements using sinusoidal motion patterns were only performed if 
individual tumor motion was >5 mm.  
 
Two Gafchromic EBT films were placed in one coronal plane in the lung insert to measure 
the dose distribution. By calibrating two films with a known dose distribution for each 
measurement session, an absolute dosimetry could be performed. As described previously 
[16], the averaging of data from two films allows for an increase of the accuracy for the 
measured plane to 1.3% (1 standard deviation). Films were scanned at least 12 hours after the 
irradiation on an Epson flatbed scanner with a resolution of 0.35 mm.  
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Plans with more than 2 arcs consisted of copies of one clockwise and one counter clockwise 
arc, and only one of each was calculated and measured on the phantom. The plans created 
with excessive MLC modulation were delivered with a range of peak-to-peak motion 
extending up to 25 mm.  
 
Evaluation 
Evaluation was done in OmniPro I’mRT software (IBA Dosimetry, Germany). For static 
plans, measurements were compared to calculations derived using AAA using gamma-
evaluation with tolerance values for dose of 3% of central PTV dose and distance to 
agreement of 2 mm, respectively. To determine the dose deviations caused by possible 
interplay effects of MLC-motions with target motion, static dose measurements were 
convolved with the sinusoidal motion pattern. The convolution was performed in OmniPro 
I’mRT. The dose distributions from static measurements were duplicated and the origins of 
the dose distributions were relocated accordingly to the excursion positions of 10 equally 
spaced time bins in the sinusoidal motion pattern. The convolutions were obtained from the 
sum of all these dose distributions. The results were compared to the measurements with 
motion with tolerance values for dose and distance of 3% and 1 mm, respectively.  
 
The relative film area with gamma > 1, the average γ-value and maximum γ -value were 
collected for analysis for the film area receiving a dose of at least 1 Gy.  
 
Results  
 
Table 2 summarizes the results of the gamma analysis for both static measurements versus 
AAA calculations (n=20 patients), and for dynamic measurements versus convolutions based 
on static measurements (n=15 patients). The data from single arcs, counter clockwise (CCW) 
and clockwise (CW), and the sum plans were listed.  
 
Table 2: Summary of gamma-analysis for static measurements versus calculations (left panel), and dynamic 
measurements versus convolutions (right panel), for 20 and 15 patients respectively. The data from single arcs, 
counter clockwise (CCW) and clockwise (CW), and the sum plans were listed. 
 Mstatic VS AAA Mdynamic VS Mstatic convolution 
 γ > 1, % Max γ Mean γ γ > 1, % Max γ Mean γ 
CCW 2.3 ± 2.3 1.44 ± 0.25 0.37 ± 0.07 1.6 ± 2.0 1.28 ± 0.23 0.36 ± 0.07 
CW 3.4 ± 3.1 1.51 ± 0.24 0.38 ± 0.08 0.9 ± 1.3 1.31 ± 0.37 0.31 ± 0.07 
Sum 2.0 ± 2.5 1.41 ± 0.23 0.36 ± 0.07 0.3 ± 0.4 1.11 ± 0.18 0.29 ± 0.05 
 
For the single-arc analysis, the average surface with gamma > 1 was 2.9% (range 0.0% - 
12.7%). For the sum plan, this was reduced to 2.0% (0.2% - 7.5%). The maximum dose 
deviation near the center of the PTV ranged from 1% - 9% for a single arc, which decreased 
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to 1% - 4% for the sum plan. Figure 2 illustrates the worst case where 12.7% of the surface 
failed the gamma criterion in a single CCW arc plan, which decreased to 2% in the sum plan 
of both CCW arc plan and CW arc plan. Largest deviations between measurements and 
calculations were observed outside the spherical polystyrene insert, which appears also from 
the gamma evaluation in Figure 2. 
 
 
Figure 2. Dose profile (a, b) in longitudinal direction and gamma evaluation (c, d) of the static measurement of 
patient 18. The measured dose profiles are indicated by red lines, and green lines indicate the calculated dose. In 
the gamma evaluation, the area with gamma value larger than 1 appears in red. The sum plan (b, d) shows 
improved homogeneity and better agreement between the calculation and measurement compared to the single 
arc plan (a, c). 
 
 
Figure 3: Dose profile (a, b) in longitudinal direction and gamma evaluation (c) of the sum plan from the 
dynamic measurement. (a) shows the differences between the static measurement (red line) and convolution 
(green line). The zero position in the x-axis represents the isocenter of the field (center of the tumor). Static 
measurement shows a length of 5.2 cm of the 80% dose coverage, consisting of gross tumor volume (GTV) plus 
5 mm setup margin and 25 mm tumor motion. In the dynamic measurement, the 80% dose coverage is 2.8 cm, 
which is sufficient for GTV plus 5 mm margin (films moving together with the insert during measurement). 
This shows that the dose blurring due to tumor motion does not influence the dose to the GTV. (b) is the 
comparison between the dynamic measurement (red line) and the convolution (green line). The gamma analysis 
(c) shows good correspondence between the dynamic measurement with the convolution with maximum dose 
deviation near to the tumor central of 3%.  
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The results from dynamic measurements for the clinical cases show a high degree of 
agreement when compared to the convolution of the static measurement, with on average 
0.3% of the surface violating the gamma criterion of 3% in dose and 1 mm in distance. 
Similar to the findings seen for static measurements, sum plans for dynamic measurements 
show better agreement to the convolutions, with surface gamma-value larger than one 
reduced from 1.3% (range 0 – 6.25%) for the  single arc to 0.3% (0 - 1.3%) for the sum plan. 
The dose deviation in the center of the PTV due to the interplay effect averaged 1% - 2% 
with only one case (single arc) exhibiting dose deviation of 4%.   
 
Table 3 shows the gamma analysis of the dynamic measurements for the additional plans 
with excessive MLC leaves modulation (60 – 70% extra monitor units compared to clinical 
plans) delivered at tumor motion of 25 mm. The maximum dose deviation in the center of the 
PTV due to the interplay effects was 5% for the single arc. Sum plans showed better 
agreement with only 1.5% of the surface failing the gamma criterion and the maximum dose 
deviation was reduced to 3% as shown in the example in Figure 3. 
 
Table 3: Gamma analysis of plans with excessive MLC leaves motion (60 - 70% more monitor units compared 
to clinical plan) delivered with tumor motion of 25 mm. Data are presented for both the single arcs, counter 
clockwise (CCW) and clockwise (CW), and for the sum plans. 
Case  γ > 1, % Max γ Mean γ 
Max dose deviation in PTV 
due to interplay effects, % 
P5 CCW  4.5 2.00 0.48 ± 0.30 5 
 CW  9.4 1.90 0.46 ± 0.36 4 
 Sum 1.5 1.38 0.40 ± 0.24 3 
P12 CCW 4.4 2.00 0.40 ± 0.31 4 
P14 CCW 3.3 1.74 0.35 ± 0.27 4 
 
Discussion 
 
Accurate patient specific QA for IMRT treatment of lung cancer is more complex than for 
most other treatment sites. Tissue is largely inhomogeneous and the influence of organ/tumor 
motion has to be investigated. Dosimetric verification of RapidArc has been conducted in 
several institutes [7, 17] for various anatomical sites with good agreement. Other studies to 
access the accuracy of AAA for lung treatment [18-19], showed that the deviations between 
measurement and AAA calculation in lung regions were well below 3%. However, no data 
was yet available about dosimetry of RapidArc in a heterogeneous phantom nor about the 
dosimetric influence of tumor motion in combination with stereotactic hypofractionated 
RapidArc delivery. 
 
Volumetric modulated arc therapy for stereotactic body radiotherapy: Planning considerations, delivery accuracy and efficiency 
________________________________________________________________________________________________________________ 
 
 68 
Our study demonstrates the high accuracy of RapidArc delivery and indicates that the 
dosimetric impact of the interplay between MLC and tumor motion can be neglected for stage 
I lung tumors. Measurement with highly modulated MLC motion in a moving phantom up to 
25 mm showed less than 2% of surface in the sum plan exceeding gamma criterion of dose 
difference of 3% and distance to agreement of 1 mm. There was good agreement between 
static measurement in the Quasar lung phantom with AAA calculation, particularly in high 
density area which consisted in most cases of a sphere with 3.0 cm diameter, and in 7 cases of 
a sphere with 1.5 cm diameter. The gradients of the measurements agreed with AAA 
calculation within a distance of agreement of 2 mm in all cases. Discrepancies at the PTV 
dose area located outside the sphere could range up to 6%, but it did not violate the criteria 
applied in our ROSEL study protocol where the maximum dose in the target is recommended 
to be between 110% and 140% of the prescription dose [5].  For individual patients, clinical 
plans were checked to ensure that the location of the higher measured dose did not coincide 
with the position of an organ at risk.  
 
The largest interplay effect occurred in the three cases with plans with highest modulation in 
combination with a large tumor motion. However, the sum plan from both arcs reduced the 
maximum dose deviations significantly. These results support our approach of using two arcs 
for RapidArc delivery.  
 
The minor role of interplay effects in our study can be explained by the following reasons. 
Firstly, RapidArc delivers volumetric modulated dose to the entire tumor volume 
continuously during gantry rotation using a collimator angle between 40° and 45°. As a 
result, the direction of tumor motion will not be constantly perpendicular or parallel to the 
MLC leaf motion. Court et al. [20] have shown that leaf motion constantly perpendicular or 
parallel to the tumor motion can lead to a more than 10% dose discrepancy in IMRT delivery. 
In addition, the MLC leaves in RapidArc plans move in both directions and not in only one 
way as is typical for sliding window IMRT. All of the above reduces the risk of the interplay 
effect between MLC/tumor. The differences in dose distributions are much smaller after the 
averaging effect of the sum plans, a finding consistent with the concept of dose average effect 
after large number of fractions proposed by Bortfeld et al [14]. A recent publication [21] has 
shown interplay effects for RapidArc exceeding dose differences of 5% for 40% of the 
surface for plans of 2 Gy per fraction. In contrast, our study has investigated the interplay 
effect for higher fraction doses where a minimum of 1660 MU were delivered, and for an 
average PTV dose of at least 9 Gy. As a result, our interplay effect may have been lower due 
to a larger averaging effect of a large single fraction delivered during at least 33 breathing 
cycles. 
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One of the limitations of this study is that the interplay effect was only studied for superior-
inferior motion of the tumor. For most of the tumors in this study, motion was greatest in this 
direction. Sixel et al [22] has also reported that the motion for lung tumor was minimal in the 
anterior-posterior and lateral direction. Another limitation could be that it is not certain that 
maximum leaf modulation together with largest tumor motion causes the maximum interplay 
as interplay is a subtle interference between leaf motion and tumor motion, which might 
correlate better with another leaf or tumor motion. However, our study for a wide range of 
clinical plans and for highly modulated plans delivered on large motion amplitude has shown 
that the effect is not significant.     
 
In our study, the only effect observed from the RapidArc measurements on moving targets is 
the dose blurring effect. In contrast, dose artefacts on moving targets have been reported to be 
significant with helical tomotherapy [13]. The authors reported 3 effects, dose rounding, dose 
rippling and asynchronization. The latter has the largest clinical impact, which is caused by 
the interplay between the leaf opening and tumor motion. It is similar to the interplay effect 
as investigated in the present study. The asynchronization tends to cause asymmetric dose 
profiles along the moving axis, resulting in dose differences ranging from -29% to 7% for 30 
mm peak to peak amplitude. The asynchronization effect was plan-specific and is present for 
a wide range of tumor motion periods. Therefore, this major dose perturbation cannot be 
predicted without running a simulation or measurement but the clinical reality is that the 
breathing pattern of a patient varies, both during and between fractions.  
 
In conclusion, our findings suggest that the risk of under-/overdosing the tumor due to 
interplay effects is not a significant problem with RapidArc delivery. The interplay effect 
does not result in unexpected dose variation, and the dose gradient at the edge of the PTV, 
obtained from dynamic measurement, agreed within 1 mm compare to static-convolved 
measurement.    
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Abstract 
 
Purpose: To investigate the impact of the calculation resolution of the anisotropic analytical 
algorithms (AAA) for a variety of small fields in homogeneous and heterogeneous media and 
for RapidArc plans.  
 
Methods: Dose distributions calculated using AAA version 8.6.15 (AAA8) and 10.0.25 
(AAA10) were compared to measurements performed with GafChromic EBT film, using 
phantoms made of polystyrene or a combination of polystyrene and cork.  The accuracy of 
the algorithms calculated using grid resolutions of 2.5 and 1.0 mm was investigated for 
different field sizes, and for a limited selection of RapidArc plans (head and neck, small 
meningioma, and lung). Additional plans were optimized to create excessive multileaf 
collimator modulation and measured on a homogenous phantom. Gamma evaluation criterion 
of 3% dose difference and 2- or 1-mm distance to agreement (DTA) were applied to evaluate 
the accuracy of the algorithms.   
 
Results: For fields ≤ 3 x 3 cm2, both versions of AAA predicted lower peak doses and 
broader penumbra widths than the measurements. However, AAA10 and a finer calculation 
grid improved the agreement. For RapidArc plans with many small MLC segments and 
relatively high number of monitor units, AAA8 failed to identify small dose peaks within the 
target. Both versions performed better in polystyrene than in cork. In homogeneous cork 
layers, AAA8 underestimated the average target dose for a clinical lung plan. This was 
improved with AAA10 calculated using a 1 mm grid.  
 
Conclusion: AAA10 improves the accuracy of dose calculations, and calculation grid of 1.0 
mm is superior to using 2.5 mm, although calculation times increased by factor of 5. A 
suitable upper MU constraint should be assigned during optimization to avoid plans with high 
modulation. For plans with a relative high number of monitor units, calculations using 1 mm 
grid resolution are recommended. For planning target volume (PTV) which contains 
relatively large area of low density tissue, users should be aware of possible dose 
underestimation in the low density region and recalculation with AAA10 grid 1.0 mm is 
recommended.
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Introduction 
 
The advent of the Multileaf Collimator (MLC) has revolutionized the art of radiation 
delivery. Highly conformal dose distributions can be achieved using different techniques of 
MLC-based intensity modulated radiotherapy (IMRT), including volumetric modulated arc 
therapy.  However, the delivery of IMRT usually involves a larger amount of small MLC 
openings compared to static 3D conformal radiation delivery techniques. The dosimetry of 
small fields poses several problems due to the absence of electron equilibrium [1]. For 
precise dose calculations in the treatment planning systems (TPS), modeling of the lateral 
scatter of electrons must be well-accounted for.  
 
RapidArcTM (Varian Medical Systems, Palo Alto) is a form of volumetric modulated arc 
therapy in the Eclipse treatment planning system [2], which was introduced in 2008. Eclipse 
uses the Analytical Anisotropic Algorithm (AAA) for RapidArc dose calculations [3-4]. The 
AAA algorithm has been extensively tested under different circumstances and compared to 
measurements and other dose calculation algorithms. Most reports showed good agreement 
between AAA and Monte Carlo simulation [5-6], and revealed the improved accuracy of 
AAA over the pencil beam convolution (PBC) algorithm, particularly in low density material 
and in heterogeneous media [5,7-9]. However, the accuracy of AAA for fields smaller than 3 
x 3 cm2 in different media, and the dosimetric accuracy of some complex RapidArc plans, 
has not been studied in detail.  
 
Previous studies of the dosimetric accuracy of RapidArc plans generally revealed good 
agreement between calculations and measurements [10-13]. This is partly because of most 
patient’s specific QA is performed in a homogeneous phantom, even when the plans are 
meant to deliver dose to heterogeneous media such as lung cases. In addition, higher spatial 
dose modulations with steep dose gradients have been measured using film dosimetry than 
those predicted by AAA calculations [10,13]. In a typical RapidArc plan, the field segments 
generated by the MLC comprise of different apertures including single opened/closed 
isolated leaves pairs, and disconnected small MLC segments. In some complex RapidArc 
plans that generate steep dose gradients [14-15], the optimizer is likely to generate more 
small MLC segments, which is associated with a higher number of monitor units (MU). This 
high irregularity of MLC openings in a plan has been associated with a lower dosimetric 
accuracy of AAA [16]. Also for very small target sizes, as in stereotactic radiotherapy, or in 
heterogeneous media, dosimetric accuracy of AAA might be inadequate.  
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For a small static 1 x 1 cm2 field in water equivalent material, AAA has been reported to 
underestimate the dose up to 6% compared to measurements [11]. For a single isolated MLC 
leaf field (leaf width of 5 mm), Gange et al. demonstrated a dosimetric error of AAA 
calculations of as high as 12% [12]. Such deviations could even be larger when using the 
high definition HD-MLC [17] as single leaf opening creates a field of only 0.25 cm wide.  
 
In this study, we investigated the accuracy of two AAA algorithms, version 8.6.15 (AAA8) 
and version 10.0.25 (AAA10), using a variety of small static fields in homogeneous and 
heterogeneous media. The most important difference between the two versions is that the 
fluence modeling has been refined from 2.5 mm in AAA8 to 0.3125 mm in AAA10. The 
dosimetric accuracy of complex RapidArc plans which are associated with more small MLC 
segments was also investigated. As the accuracy of AAA is expected to decrease in low 
density media [8,18], we also compared dose calculations for a typical RapidArc plan for 
lung stereotactic body radiotherapy (SBRT) with measurements in different heterogeneous 
phantoms, and evaluated the actual dosimetric implications.  
 
Materials and Methods 
 
Measured dose distributions were compared with calculations from two versions of the AAA 
algorithm. Both versions were configured using the same beam data measured in a large 
water phantom (IBA, Schwarzenbruck, Germany) for different field sizes ranging from 3 x 3 
cm2 to 40 x 40 cm2. Dose profiles were measured with a shielded diode detector (PFD, IBA, 
Schwarzenbruck, Germany), while percentage depth dose (PDD) curves and output factors 
were measured using ionization chamber (CC 13, IBA, Schwarzenbruck, Germany). All 
beam data measurements were carried out at a source to surface distance of 100 cm and the 
output factors were measured at depth of dose maximum, dmax.  
 
The accuracy of the dose calculation algorithm was determined by comparing calculated dose 
distributions with those measured using film dosimetry in different phantoms. The applied 
fields ranged from small static symmetric and asymmetric fields, to clinical RapidArc plans. 
A Varian Trilogy accelerator equipped with the Millennium Multileaf Collimator (leaf width 
of 5 mm at isocenter), and a Varian Novalis Tx accelerator equipped with the HD-MLC with 
leaf width of 2.5 mm at isocenter, were used for the delivery. The dosimetric leaf gaps and 
transmission factors configured in the beam data of the planning system for the millennium 
MLC and the HD-MLC were 2.1 mm and 1.6%, and 0.9 mm and 1.0%, respectively.  All 
plans used 6 MV photon beams. Dose calculations were performed with both versions of the 
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AAA using calculation grids of 2.5 mm and 1.0 mm, taking into account heterogeneity 
correction.  
 
 
Fig. 1. Phantoms used for dose measurement, in transversal view, with arrows indicating the measuring plane. 
(a) and (c) are 2 different homogeneous polystyrene phantoms. (b) is a heterogeneous phantom consisting of 3 
cm of polystyrene at the top and bottom, with 6 cm of cork in the middle. (d) and (e) are lung phantoms without 
and with a polystyrene sphere, representing a tumor.  
 
All measurements were performed at a fixed source-detector distance of 100 cm. Fig. 1 
shows the various phantoms used in this study. During the measurements, two pieces of 
GafChromic EBT film (International Specialty Products, Wayne, New Jersey) were placed 
simultaneously at one coronal plane in the phantom. An absolute dose calibration was 
performed by irradiating two films with a known dose distribution during each measurement 
session. Films were scanned at least 12 hours after the irradiation on an Epson 1680 
Expression Pro transmission flatbed scanner (Epson Seiko Corporation, Nagano, Japan) in 
combination with a Silverfast driver. The scanner has been configured to scan with 72 dpi (~ 
0.35 mm / pixel). More details of our GafChromic film processing have been reported 
previously [19].  
 
Film measurements were compared to dose calculations in the OmniPro I’mRT software 
(IBA Dosimetry, Germany) using gamma evaluation method [20]. Film measurements were 
smoothened using a 2D median filter of 3 x 3 pixels for noise reduction and manually aligned 
with the calculated dose distributions. Due to the higher resolution in measurements than in 
the exported dose distributions from the TPS (~ 0.35 vs 0.59 mm / pixel), all gamma 
evaluations were calculated using AAA calculations as the reference. For the gamma 
criterion, tolerance values for dose of 3% of the average measured dose in the target region 
from the measurement, and distance to agreement (DTA) of 2 mm were generally applied. As 
high spatial dose modulations were detected using film [10], the use of DTA of 2 mm could 
provide more opportunities to match the dose points between measurements and calculations, 
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resulting in more favourable gamma outcomes. Therefore, a DTA of 1 mm was applied in 
selected cases to study the influence of DTA on the outcome of gamma analysis. Points 
failing the gamma criterion will exhibit a gamma value larger than 1. At the measured plane, 
a rectangular region of interest (ROI) was defined to encompass only the high dose region 
confined to the PTV volume, including the dose fall off gradients at the borders of the PTV. 
The percentages of points within the ROI that failed the gamma criterion were assessed as a 
measure of disagreement between measurements and calculations.   
 
A. Static Small Fields 
Dose distributions of small fields were measured in polystyrene (Fig. 1a) and in cork (Fig. 
1b) at 6 cm depth.  Square field sizes of 1 x 1 cm2, 1.5 x 1.5 cm2, 2 x 2 cm2, and 3 x 3 cm2 
were measured, all defined by the MLC. The collimator was set 1 cm larger than the MLC 
field, with a minimum of 3 x 3 cm2. Each measurement was repeated twice, and averages 
were used for analysis. In addition, dose profiles were also measured for a typical MLC 
segment of a RapidArc plan on the Novalis Tx in which 2 isolated leaf pairs (2.5 mm leaf 
width) were opened with one closed leaf pair in between. For this asymmetric field, the 
collimator was set at 3 x 3 cm2. All fields were directed orthogonal to the phantom surface at 
gantry and collimator angle of 0°. Each field was delivered and calculated using 600 MU, 
corresponding to absorbed doses of 3 – 5 Gy (depending on the field size and phantom 
media).  
 
For the square fields, the deviations in dose and penumbra width (width of the dose fall-off 
from 90% to 50% of the central dose in the direction parallel to the MLC leaves) between 
calculations and measurements were reported. For asymmetric MLC fields, the dose profiles 
in the direction perpendicular to the MLC were compared.  
 
B. Clinical RapidArc Plans 
1. Monitor Units Modulation Tests 
Two clinical head and neck cases, treated using a simultaneously integrated boost technique 
on the Varian Trilogy accelerator with 120-leaf Millennium MLC, were randomly selected. 
Both cases were treated using a RapidArc plan consisting of 2 consecutively planned arcs, 
namely a counter-clockwise (CCW) and a clockwise (CW) arc, where the second arc was 
optimized by referring to the dose distribution of the first calculated arc plan and 
compensates for any underdosage area in the PTV [10]. For each case, 2 additional RapidArc 
plans were created. In order to create plans with 20 – 100 % extra MU as compared to the 
original clinical plan, the new plans were re-optimized using stronger constraints on organs at 
risk and, if necessary, a minimum MU objective. All plans had the same prescription dose to 
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the PTV. Consequently, the plans with higher number of MU consisted of an increased 
number of small effective field sizes, i.e. more leaf modulation. Fig. 2 illustrates an example 
of a RapidArc MLC setting, showing single leaf blocking, opening, and several small MLC 
segments.    
 
Fig. 2. Typical RapidArc MLC setting, consisting of single leaf blocking/opening and several small effective 
fields.  
 
The measurements were carried out in the homogeneous polystyrene phantom (Fig. 1c). 
Calculations of dose distribution in the phantom were performed for both versions of AAA 
using the grid resolutions of 2.5 mm and 1.0 mm.   
 
To study the accuracy of a RapidArc plan with extreme modulation (high amount of small 
MLC segments) for the HD-Millennium MLC on the Novalis Tx, plans of a patient treated 
for a small meningioma were investigated. The patient had a relatively small PTV (4.6 cm3), 
located close to the right eye, overlapping with a part of the right optical nerve. A dose of 54 
Gy in 27 fractions was prescribed to the PTV. The plan was optimized such that the PTV 
received between 95 and 107% of the prescribed dose, while limiting the dose to the optical 
nerve inside the PTV to < 100% and sparing the brainstem, pituitary gland, eye lenses, and 
optical nerve. As a result, the plan required a high number of monitor units (694 MU to 
deliver 2Gy per fraction), with heavy modulation of the MLC. The plan was measured in the 
polystyrene phantom using GafChromic film as part of the routine patient QA. Measured 
dose distributions were compared to calculated dose distributions using both versions of 
AAA8 and AAA10 with grid sizes of 2.5 and 1.0 mm.  
 
 
 
Volumetric modulated arc therapy for stereotactic body radiotherapy: Planning considerations, delivery accuracy and efficiency 
________________________________________________________________________________________________________________ 
 
 80 
2. RapidArc Lung Plan 
To investigate the performance of AAA in low density material, a highly modulated clinical 
stereotactic RapidArc lung plan generated for the Varian Trilogy accelerator was measured. 
The plan was optimized such that 95% of the PTV received at least the nominal fraction dose 
of 60 Gy in 8 fractions, with a maximum dose within the PTV between 110% and 140% of 
the prescribed dose [21]. The plan was measured in 3 different phantoms: the homogeneous 
polystyrene phantom, the lung phantom with homogeneous cork layers surrounded by 
polystyrene (Fig. 1d), and the lung phantom with a small polystyrene sphere (diameter = 2.4 
cm) in between the cork layers to imitate a tumor (Fig. 1e). The calculations were performed 
using both versions of AAA and calculation grids of 2.5 and 1.0 mm. Gamma analyses and 
the differences in absolute dose between the measurements and calculations within the ROI 
were reported.  
 
Results 
 
A. Static Small fields 
For square fields larger than 1 x 1 cm2 measured in polystyrene, the dose calculated using 
both versions of AAA agreed within 2% of measurements (Fig. 3a). For the 1 x 1 cm2 field, 
AAA8 underestimated the peak dose (maximum dose at the center of the field) by 4.5% and 
3.1% with calculation grids of 2.5 mm and 1.0 mm respectively. For comparison, AAA10 
showed 4.3% and 1.3% underdosage, respectively. In cork, the algorithm systematically 
underestimated the peak dose (Fig. 3b.). The peak dose of the 3 x 3 cm2 field was calculated 
2 – 3% too low by both versions, but the largest deviation arose for the 1 x 1 cm2 field (9.8% 
for AAA8 and 6.8% for AAA10). By changing the calculation grid from 2.5 mm to 1.0 mm, 
deviations between calculations and measurements for this field were reduced to 5.9% and 
2.0% for AAA8 and AAA10, respectively.  
 
The differences in penumbra width, i.e. the distance from 90% – 50% of the peak dose, 
between calculations and measurements in polystyrene and cork are shown in Fig. 3c and 3d. 
Generally, AAA predicted a broader penumbra than the measurements, especially in cork 
(note that the scaling for the y-axes is different in both figures). AAA10 consistently 
demonstrated better agreement with measurements than AAA8 in both polystyrene and cork.  
 
Dose profiles for asymmetric fields over two isolated MLC leaf pair openings (2.5 mm leaf 
width) are shown in Fig. 4a and 4b. AAA10 demonstrated good agreement with 
measurements for both calculation grids. For AAA8, a calculation grid of 1.0 mm 
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underestimated the peak dose by ~15% in both polystyrene and cork, whereas a calculation 
grid of 2.5 mm failed to identify the distinctive peaks and valley.  
 
 
Fig. 3. Comparison between measurements and calculations using AAA8 and AAA10 with calculation grids of 
2.5 mm and 1 mm. (a) and (b) show the dose deviations between measurements and calculations in polystyrene 
and cork. (c) and (d) show the calculated and measured penumbra width for small square fields. 
 
 
 
Fig. 4. Measured and calculated dose profile for the 2 open HD-MLC leaves separated by one closed leaf.   
 
B. Clinical RapidArc plans 
1. Monitor Units Modulation Tests 
Table I summarizes the results of the gamma analysis between measurements and 
calculations for RapidArc plans with different levels of MU (i.e. MLC-modulation). Results 
of 2 gamma analyses (3% dose difference and DTA of 2 mm and 1 mm) presented were 
averaged for 2 arcs, (one CCW and one CW arc per plan), and for 2 patients. Both versions of 
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AAA performed better in plans requiring less dose modulation (less MU). For these plans, 
calculations using a 1 mm grid resolution agreed very well with those calculated using a 2.5 
mm grid.  
 
Table I: Gamma analysis of plans with different number of monitor units. Percentages of gamma >1 within the 
region of interest listed were averaged for 2 arcs, (one counter clockwise and one clockwise arc per plan), for 2 
patients. 
MU Version Gamma >1, % (Gamma Dose 3%, DTA 2mm / 1 mm) 
  Grid 2.5 mm Grid 1.0 mm 
328 AAA8 0.3   /   2.0 0.1   /   1.3 
 AAA10 0.1   /   0.9 0.1   /   0.4 
457 AAA8 1.5   /   7.6 1.0   /   4.2  
 AAA10 1.3   /   6.2 0.8   /   3.4  
598 AAA8 2.4   /   11.4 1.9   /   8.2 
 AAA10 1.5   /   7.8 1.0   /   4.5 
 
Fig. 5 shows the measured and calculated dose profiles of 2 arcs with different amount of 
modulation, one using 372 MU and the other with 668 MU, respectively. Measurements 
demonstrated higher dose modulation than predicted by the AAA8 calculations using a grid 
of 2.5 mm, particularly in the plan with the highest number of MU. Only in plans with a large 
number of MU did the choice of gamma criterion, a DTA of either 2 mm or 1 mm, influence 
the outcomes of the gamma evaluation.  
 
 
Fig. 5. Measured and calculated dose profiles for 2 arcs with total monitor units of 372 (left) and 668 (right), 
respectively. 
 
Fig. 6 illustrates the dose profiles for the selected RapidArc meningioma plan. AAA8 failed 
to identify the sharp peak located at the edge of the PTV for both grid sizes, resulting in a 
local dose difference of 13%. AAA10 using a calculation grid of 1.0 best predicted the dose 
profile in comparison with the film measurement. The gamma analyses are listed in Table II.  
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Fig. 6. Measured and calculated dose profiles for the clinical meningioma RapidArc plan in a homogenous 
polystyrene phantom. 
 
TABLE II: Gamma analysis of the clinical meningioma RapidArc plan. 
   
 
 
 
 
2. RapidArc lung plan 
Table III shows the gamma evaluations of a clinical lung plan measured and calculated in 3 
different phantoms. In the homogeneous polystyrene phantom, both versions showed good 
agreement with measurements. However, in the lung phantom consisting of homogeneous 
cork layers, the average calculated dose using AAA8 was 4% lower (maximum 12%) in the 
target region, resulting in up to 21% of the ROI having gamma >1. AAA10 greatly improved 
the dose accuracy in low density material, although an average underdosage of 2% was still 
present in the target region. When a small polystyrene sphere was introduced to imitate the 
presence of a tumor, the gamma analyses showed considerable improvement. Good 
agreement was observed within the high density polystyrene, whereas the area that failed the 
gamma criterion was primarily located outside the sphere, and in low density cork (Fig. 7).  
AAA8 measurements indicated that 5 – 7% of the surface of the ROI having gamma >1, 
while this was less than 1% when AAA10 was used.  
 
 
 
 
 
 
Version Calculation Grid, mm Gamma >1 ( 3% dose, 2mm DTA), %  
AAA8 2.5 15.77 
 1.0 7.34 
AAA10 2.5 6.92 
 1.0 0.84 
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TABLE III: Gamma analysis for plans measured and calculated in different media. Percentages of gamma >1 
and average dose difference within the region of interest between measurements and calculations were listed. 
 
Version 
Calculation 
Grid, mm Parameters, % Polystyrene Cork 
Cork with polystyrene 
sphere 
AAA8 2.5 Gamma >1 1.0 21.3 6.9 
  Avg Dose Diff 1.8 3.8 2.7 
AAA8 1.0 Gamma >1 0.0 21.2 5.8 
  Avg Dose Diff 1.2 3.5 2.4 
AAA10 2.5 Gamma >1 0.1 8.5 1.0 
  Avg Dose Diff 1.3 1.9 1.7 
AAA10 1.0 Gamma >1 0.0 5.5 0.2 
  Avg Dose Diff 1.1 1.6 1.4 
 
 
FIG. 7. Gamma evaluation of measured and calculated dose distribution carried out in cork with a polystyrene 
sphere. Both calculations were performed with 2.5 mm grid. The black solid line represents the outline of the 
sphere.  
 
Discussion 
 
In this study, the dosimetry of small static fields was compared to calculations derived from 
the TPS. Modern delivery techniques such as multiple field IMRT or RapidArc commonly 
involve small irregular field openings, and often, single MLC leaf opening or blocking. The 
use of HD-MLC enhances this problem. Although several studies have demonstrated a high 
accuracy of AAA calculations in RapidArc delivery [22-23], higher spatial dose modulations 
were observed on film dosimetry as compared to AAA calculations [10]. In addition, 
RapidArc measurements in inhomogeneous media have not yet been reported. We have 
shown that the calculation accuracy of AAA10 is superior to that of AAA8, and that using a 
calculation grid resolution of 1.0 mm is superior to 2.5 mm. The improved accuracy in 
AAA10 can be attributed to the higher fluence resolution.  
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In small symmetric fields, AAA8 overestimated the measured penumbra widths, a finding 
reported previously [11]. Compared to AAA8, AAA10 improved penumbra modeling, and 
AAA10 calculations using a grid size of 1.0 mm showed excellent agreement in polystyrene. 
In contrast, AAA8 calculated using 2.5 mm grid constantly overestimated the penumbra 
width by 1 – 1.3 mm in both polystyrene and cork. Both versions of AAA performed better in 
polystyrene (muscle tissue equivalent) than in cork (lung tissue equivalent), where the 
algorithms underestimated the absorbed dose by as much as 10 % for the smallest MLC field 
using AAA8. Other studies have also reported on the underestimation of doses in lung by 
AAA [8,24-25]. However, overestimation by AAA of up to 40% for a 1 x 1 cm2 field in lung 
tissue was reported by Rosa et al [18]. It should be noted that Rosa et al. compared PDD 
estimates by AAA and Monte Carlo simulations. As the PDD was normalized to the local 
maximum of each dose profile, the absolute differences in maximum dose between different 
PDD were not stated.  
 
In AAA8, the calculated dose for small fields is smeared out, resulting in a lower maximum 
dose and broader penumbra. In heterogeneous phantom, lower accuracy was observed in the 
low density region within the PTV volume for AAA8 calculations using a 2.5 mm grid. We 
then performed an AAA10 calculation using 1 mm grid resolution of the same plan on patient 
anatomy and this revealed that the mean PTV dose and ITV dose were 3.6% and 2.4% higher 
in AAA10, respectively. Doses to other organs at risk were comparable between the 2 
versions. As a maximum dose for SBRT lung plans of 140% of the prescription dose is 
permitted [21], an overdosage of ~ 3% in the PTV is acceptable. However, if the PTV dose is 
likely to be clinically relevant, users are recommended to recalculate the plans using AAA10 
with grid resolution of 1.0 mm. 
 
The influence of calculation grid on calculation accuracy has been investigated by several 
authors. Gange et al. recommended that RapidArc plans be calculated only at a resolution of 
2.5 mm or better [12]; while Panettieri et al. [26] reported only small deviations in AAA if 
the grid size is increased from 2 mm to 5 mm for static fields ≥ 3 x 3 cm2. We have 
demonstrated dose differences up to 20% for small MLC fields, and 5% for a RapidArc plan 
by changing the grid size from 2.5 mm to 1.0 mm.  
 
The effects seen for small fields do not directly translate to RapidArc plans measured in a 
homogeneous polystyrene phantom. In most of the RapidArc plans, the dosimetric errors 
caused by a few small MLC segments are insignificant for a full arc delivery. However, in a 
highly modulated plan, the increasing amount of small MLC segments can lead to noticeable 
dosimetric errors. The correlation between the complexity of a plan and the dosimetric 
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accuracy of an algorithm has been highlighted by a similar study [16]. Kallehauge et al. [27] 
have also demonstrated that parameters such as the Modulation Complexity Score [28] and 
the number of MU are correlated to the results of a gamma evaluation.  
 
In order to reduce large dosimetric errors, plans with extreme modulation should be avoided. 
As the amount of modulation is related to the number of required MU, by using an upper MU 
constraint during the optimization, plans with extreme modulation (particularly those 
generated with HD-MLC) can be avoided. However, this approach may result in a trade-off 
between better sparing of organs at risk and better agreement between measurements and 
calculation. In addition, our previous work has demonstrated that using RapidArc plans 
consisting of 2-arcs can effectively improve the dosimetric accuracy [10,29]. In the case of a 
target located adjacent to several critical organs (particularly for a small PTV and for small 
MLC leaf width), RapidArc plans generated are likely to consist of a large number of small 
MLC segments and a dose calculation with grid resolution of 1.0 mm in AAA10 is 
recommended. For less complicated RapidArc plans without extreme dose modulation, our 
findings suggest that a grid resolution of 2.5 mm is sufficient to achieve accurate dose 
calculation.   
 
The choice of the DTA in the gamma evaluation can largely influence the evaluation of 
measured versus calculated dose. The DTA is designed for dose comparison at regions of 
sharp dose gradients. When a large amount of small dose modulations with sharp gradients is 
present in a measured dose distribution, e.g. caused by noise, the gamma evaluation will still 
show good agreement when comparing with a smoother calculated dose distribution [30]. A 
RapidArc plan with a relatively high number of MU, comprised of many small MLC 
segments, can result in a higher modulation in measured dose compared to calculation as 
shown in Fig. 5.  The use of a relatively large DTA of 2 or 3 mm provides more opportunities 
in the gamma evaluation to match a calculated dose point with a nearby measured dose point, 
leading to a possible higher percentage of points passing the criterion, and thus in a higher 
acceptance of plans. This was demonstrated for RapidArc head and neck plans with different 
levels of modulation. An appropriate DTA criterion should be adopted particularly for the 
evaluation of plans with high dose modulation, unless the high dose modulation is not 
considered as clinically important.  
 
One limitation of this study was the uncertainty of the film dosimetry measurements. 
GafChromic EBT films were used as the benchmark due to their high spatial resolution and 
limited energy dependency [31-32]. Although EBT films have shown good agreement with 
Monte Carlo simulation [33-34] in small field dosimetry, van Battum et al. [19] showed a 
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standard deviation of 1.3% for EBT film dosimetry by averaging the data from two 
simultaneously irradiated films. Although this value was obtained for dose up to 2.3 Gy, it 
was also reported in the article that the scan uncertainty as a function of optical density (OD) 
remains small between 0.5 up to 2.5. In our experiments, the investigated dose range was 
below 8 Gy, which correspond to OD ~ 1.0. In addition, Devic et al. and Fiandra et al. have 
also demonstrated that the uncertainty of EBT films is the same or lower, for doses above 0.4 
Gy [35-36]. Therefore, the uncertainly of 1.3% reported in van Battum et al. is still applicable 
for the dose range investigated. This is also suggested by the stability for small field 
dosimetry in Fig. 3a, e.g. for the comparison of measurements with symmetrical fields in 
polystyrene calculated using AAA10 1 mm grid, the results remain stable within 0.2% for 
field sizes of 1.5 x 1.5 cm2 to 3 x 3 cm2. 
 
Finally, it is important to mention that calculations using 1.0 mm calculation grid are  more 
time consuming than those calculated with a standard grid resolution of 2.5 mm. Most 
calculations were carried out on a 2.5 GHz Intel Xeon processor with 16 GB RAM, running 
the Microsoft window XP professional x64 edition. Calculation times for single arc in a 
phantom with couch support (collimator setting of 300 – 500 cm2) were approximately 20 
and 100 minutes, for the grid resolutions of 2.5 mm and 1.0 mm respectively.  
 
Conclusion 
 
This study demonstrates that an enhanced calculation resolution improves the accuracy in 
AAA dose calculations, particularly in small field dosimetry and for highly modulated 
RapidArc plans. In lung tissue and for high density targets surrounded by lung tissue, a 
substantial fraction of the AAA8 calculated dose distribution fails the gamma criterion. This 
is improved through the use of AAA10 and a 1 mm dose calculation grid.  
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Abstract  
 
Purpose: Flattening filter free (FFF) beams with higher dose rates and faster delivery are 
now clinically available. The purpose of this planning study was to compare optimized non-
FFF and FFF RapidArc plans for stereotactic body radiotherapy (SBRT), and to validate the 
accuracy of fast arc delivery.   
 
Methods and Material: Ten patients with peripheral lung tumors and ten with vertebral 
metastases were planned using RapidArc with a flattened 6 MV photon beam and a 10 MV 
FFF beam for fraction doses of 7.5 to 18 Gy. Dosimetry of the target and organs at risk 
(OAR), number of monitor units (MU) and beam delivery times were assessed. GafChromic 
EBT2 film measurements of FFF plans were performed to compare calculated and delivered 
dose distributions.  
 
Results: No major dosimetric differences were seen between the 2 delivery techniques. For 
lung SBRT plans, conformity indices and OAR doses were similar, although the average MU 
required were higher with FFF plans. For vertebral SBRT, FFF plans provided comparable 
PTV coverage with no significant differences in OAR doses. Average beam delivery times 
were reduced by a factor of up to 2.5, with all FFF fractions deliverable within 4 minutes. 
Measured FFF plans showed high agreement with calculated plans, with more than 99% of 
the area within the region of interest fulfilling the acceptance criterion.  
 
Conclusion: The higher dose rate of FFF RapidArc reduces delivery times significantly, 
without compromising plan quality or accuracy of dose delivery.  
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Introduction 
 
Stereotactic body radiotherapy (SBRT) is an established treatment approach for both curative 
and palliative indications. High control rates with minimal toxicity have been reported by 
studies in early-stage non-small cell lung cancer (NSCLC) [1], and vertebral metastases [2-3]. 
These excellent outcomes are achieved by precise delivery of high radiation doses to the 
target in a single or a few fractions, while sparing the surrounding normal tissues. In order to 
achieve such high dose conformity and steep dose fall-off outside the lesion, SBRT for lung 
tumors is commonly delivered using several coplanar and non-coplanar static beams, or 
volumetric modulated arc therapy. SBRT for vertebral metastases is often delivered using 7 
or more static intensity modulated radiation therapy (IMRT) beams or volumetric modulated 
arc therapy with multiple arcs [4].   
 
SBRT delivery times are often prolonged due to the high dose/fraction, limited dose rate, use 
of multiple treatment beams and IMRT delivery. For typical SBRT treatments, the monitor 
units (MU) required for a fraction dose in excess of 10 Gy are in the range of 2000–10000 
MU. Total set-up and treatment times, inclusive of all time spent with patient on the couch 
for SBRT, can extend up to 90 minutes [2] and 60 minutes [5] for SBRT of vertebral 
metastases and NSCLC, respectively. Extended treatment times can increase the risk of tumor 
displacement during delivery [6] and necessitates extra imaging for position verification. 
Therefore, it is logical to investigate faster delivery as one component of reducing overall 
treatment time and facilitating treatment accuracy. 
 
Different volumetric modulated arc therapy approaches have been used to deliver SBRT 
[4,7]. One of these is RapidArc (Varian Medical Systems, Palo Alto, CA), which permits 
efficient delivery of highly conformal dose distributions [8]. However, in particular for high 
fraction doses, the minimum treatment time may be substantially influenced by the maximum 
dose rate. The dose rate of a beam can be increased by removal of the flattening filter. The 
resulting flattening filter free (FFF) beams have a cone-shaped dose profile [9] and up to a 
factor four higher dose rate in the center of the beam. The use of inverse planning which 
takes into account the basic beam profile facilitates the use of FFF beams. FFF delivery 
techniques have been reported for 3D conformal radiotherapy [10] and intensity modulated 
radiotherapy [11].  
 
In this retrospective study, we evaluated plan quality and beam delivery time for RapidArc 
plans for SBRT of NSCLC and vertebral metastases generated using a FFF beam, and 
compared them with plans generated using a standard flattened beam. To validate the 
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accuracy of fast arc delivery for clinical use, several FFF plans were measured using film 
dosimetry. 
 
Methods and Materials 
 
Ten patient with a stage I NSCLC and ten patients with vertebral metastases, all of whom had 
undergone SBRT at our center were re-planned for this study. One patient each with a 
vertebral metastasis and a lung tumor were clinically treated using FFF plans, while all others 
were treated using flattened beams. All plans were created using the Eclipse treatment 
planning system (version 8.9.08), and dose calculations were carried out using the 
Anisotropic Analytical Algorithm (AAA) with a grid resolution of 2.5 mm, taking into 
account heterogeneity correction. The collimator angles for all arcs were between 30° and 
45°. 
 
The mean planning target volume (PTV) for NSCLC patients was 58.2 cm3 (range 8.9–153.4 
cm3). For patients with vertebral metastases, the mean PTV was 119 cm3 (range 34.13–225.9 
cm3) and mean PTV length was 7.3 cm (2.9–11.5 cm). Two RapidArc plans were generated 
for each case, one using a flattened beam (FF) and the other a FFF beam. Clinical FF plans 
using 6 MV flattened photon beams were delivered on a Novalis Tx™ accelerator, equipped 
with a high-definition multi-leaf collimator (HD-MLC, spatial resolution of 2.5 mm at 
isocenter) at a maximum dose rate of 1000 MU/min. The FFF plans using 10 MV FFF beams 
were delivered on a TrueBeamTM accelerator, equipped with a millennium MLC (spatial 
resolution of 5 mm at isocenter) using a maximum dose rate on the central beam axis of 2400 
MU/min. The dosimetric leaf gaps and transmission factor used in the treatment planning 
system for the millennium MLC (FFF beams) and the HD-MLC (FF beams) were 1.37 mm 
and 1.4%, and 0.9 mm and 1.0%, respectively.   
 
Imaging and target definition 
For lung cases, a PTV was created by adding a margin of 5 mm to the internal target volume 
(ITV) which encompassed all motion observed on four-dimensional (4D) CT-scan [8]. 
Organs at risk (OAR) were delineated on the average intensity projection CT, including the 
contralateral lung, spinal cord, oesophagus, heart, trachea, and chest wall.  
 
For vertebral cases, the gross tumor volume (GTV) and clinical target volume (CTV) were 
delineated and the PTV was generated by adding a 3 mm margin. The spinal cord, cauda 
equina or thecal sac (referred to collectively as ‘spinal cord’) was delineated on a planning 
CT scan using MRI fusion [12]. Depending on the location of the PTV and the vertebrae, 
Fast arc delivery for stereotactic body radiotherapy of vertebral and lung tumors 
________________________________________________________________________________________________________________ 
 97 
additional OAR included liver, lungs, oesophagus, bowel, skin, kidneys, ureters and nerve 
roots or nerve plexus. To account for various sources of positional uncertainty during image-
guided vertebral SBRT, a spinal cord planning at risk volume (PRV) was created by adding a 
2 mm margin to the spinal cord [13].  
 
Treatment planning technique 
Lung SBRT was delivered using a ´risk adapted´ fractionation scheme of either 3 fractions of 
18 Gy (n=4), 5 fractions of 11 Gy (n=3), or 8 fractions of 7.5 Gy (n=3), determined by T-
stage and proximity to the adjacent normal tissues [1]. All plans were normalized such that 
the prescription dose corresponded to the 80% isodose. Details of treatment planning have 
been reported previously [8]. Planning objectives for the PTV required that 95% of the PTV 
received at least the nominal fraction dose, and that the maximum dose was 110-140% of the 
prescription dose [14]. All plans required a clockwise (CW) and a counter clockwise arc 
(CCW) for each fraction. The two different arcs were optimized sequentially for 50% of the 
dose, whereby the second arc referred to the calculated dose distribution using AAA of the 
first arc, and compensated for any under- or over-dosage in the PTV due to shortcomings in 
accuracy of the optimizer calculation algorithm in low density media [8]. FFF plans were 
optimized using the same field settings and optimization constraints.  
 
For vertebral cases, the fractionation schemes used were 1 fraction of 16 Gy (n=3), 2 
fractions of 10 Gy (n=3) or 3 fractions of 9 Gy (n=4), primarily depending on whether the 
patient had received prior radiotherapy [4,15]. The objective was to deliver the prescription 
dose to at least 90% of the PTV while sparing nearby critical structures [4, 16]. The FF and 
FFF techniques were optimized using the same dose constraints. In general, arc delivery 
times exceeding 3 minutes were avoided to allow for frequent imaging between arcs. This 
meant that some of the FF plans were planned using 3 arcs, whereas only 2 arcs were needed 
for FFF plans. The multiple arcs were optimized in one single optimization. Clinical plans 
were normalized with respect to the acceptable point dose in the spinal cord. The additional 
plans created for comparison purposes were normalized such that the same percentage of 
PTV volume was encompassed by the prescription dose as in the corresponding clinical plan. 
  
Dosimetric analysis 
Dosimetric data was derived from dose volume histograms (DVH). For lung plans, the mean 
and maximum PTV, and mean ITV doses were reported. The plan conformity was expressed 
using the Conformity Index (CI) - CI80% and CI60%. The CI80% was defined as the ratio of the 
total body volume encompassed by the 80% isodose line divided by the volume of the PTV 
receiving the same dose. The maximum dose to the spinal cord, and V40Gy (volume receiving 
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40 Gy or more) and V30Gy of the chest wall, were assessed. For vertebral plans, mean and 
maximum PTV doses, maximum dose to the skin, spinal cord and its PRV were collected. 
Finally, the number of MU required for each plan and beam delivery times were compared. 
Paired t-tests were performed with p ≤ 0.05 indicative of statistical significance. 
 
Dose measurement 
FFF plans of three lung cases and three vertebral cases were each measured using film 
dosimetry. Due to the close proximity between the PTV and spinal cord in all patients with 
vertebral metastases, 3 plans were randomly selected for the measurements. For lung cases, 
one plan from each of the fractionation schemes used with most modulation (and thus highest 
MU), was chosen for dosimetric study as such plans are most likely to exhibit 
calculation/delivery errors. All measurements were performed in a homogenous polystyrene 
phantom at a fixed source-axis distance of 100 cm. For each arc, dose distributions were 
measured in one coronal or sagittal plane, using two GafChromic EBT2 films. During each 
measurement session, an absolute dose calibration was performed by irradiating two films 
with a known dose distribution. Films were scanned at least 12 hours after irradiation on an 
Epson 1680 Expression Pro transmission flatbed scanner (Epson, Seiko Corporation, Nagano, 
Japan) with a resolution of 0.35 mm.  
 
Evaluation of measured versus calculated dose distributions was done in OmniPro I’mRT 
software (IBA Dosimetry, Germany). The measured dose distributions were smoothed using 
a 2D median filter of 3 x 3 pixels for noise reduction, and manually aligned with the 
calculated dose distributions derived from the Eclipse treatment planning system. Gamma-
evaluation tolerance values were 3% for average PTV dose, and distance to agreement (DTA) 
of 2 mm was used. Points failing these criteria resulted in a gamma value >1. A rectangular 
region of interest (ROI) was defined encompassing all the PTV area which received more 
than 20% of the prescription dose. The percentage of gamma >1 and the average and 
maximum gamma value within the ROI were collected for analysis. 
 
Results 
 
The dosimetric analyses averaged for each technique are summarized in Table 1. For lung 
cases, the average differences between the FF and FFF plans for the mean ITV and PTV dose 
were ≤ 1%. The conformity indices for the prescription dose, CI80, and 75% of the 
prescription dose, CI60, were similar between the 2 techniques, as were the OAR doses. FFF 
plans required on average 8.3% more MU (p=0.008). The average beam delivery times for 
plans with fractional dose of 18 Gy and 11 Gy were reduced from 4.8 to 2.6 minutes and 3.2 
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to 2.5 minutes, respectively, with the use of FFF beams. Beam delivery time for a fraction of 
7.5 Gy was similar for both the plans.  
 
For vertebral metastases, the mean and maximum PTV doses were 2% and 6% higher, 
respectively, for FFF plans (p <0.05 for both). All OAR doses, including that to the spinal 
cord and its PRV, showed no significant differences. The average beam delivery times were 
reduced from 6.7 (range 3.7–10.8) to 2.8 (2.5–3.8) minutes (p=0.001), while the amount of 
MU required for both techniques showed no significant difference (p=0.285). Figure 1 and 2 
illustrate the DVH comparison for a pair of vertebral plans and lung plans, respectively, with 
both techniques showing similar target coverage and OAR sparing. 
 
Table 1: Summary of dosimetric metrics for FF and FFF plans  
Sites Metric Unit FF 6X FFF 10X P-value 
Lung PTV Dmean % 112 ± 3 113 ± 3 0.348 
 PTV Dmax % 130 ± 5 133 ± 8 0.086 
 ITV Dmean % 119 ± 5 120 ± 5 0.152 
 rib V40 cm3 19.3 ± 24.5 19.7 ± 24.3 0.216 
 rib V30 cm3 46.0 ± 50.4 46.9 ± 50.4 0.219 
 CI80  1.08 ± 0.3 1.08 ± 0.4 0.318 
 CI60  1.97 ± 0.18 1.99 ± 0.20 0.282 
 cord Dmax Gy 11.9 ± 7.4 12.6 ± 6.9 0.236 
 Monitor units/Dose MU/Gy 228 ± 18 247 ± 26 0.008 
 Time min 3.6 ± 1.0 2.5 ± 0.1 0.007 
 3 x 18 Gy (n=4)  4.8 ± 0.4 2.6 ± 0.1 - 
 5 x 11 Gy (n=3)  3.2 ± 0.2 2.5 ± 0.1 - 
 8 x 7.5 Gy (n=3)  2.5 ± 0.1 2.5 ± 0.1 - 
      
Spine PTV Dmean % 112 ± 4 114 ± 4 0.004 
 PTV Dmax % 142 ± 4 148 ± 9 0.009 
 Spinal Cord Dmax Gy 13.5 ± 5.3 13.4 ± 5.4 0.536 
 PRV Dmax Gy 17.9 ± 5.4 17.5 ± 5.2 0.227 
 Skin Dmax Gy 11.1 ± 5.0 10.9 ± 4.9 0.209 
 Monitor Unit/Dose MU/Gy 528 ± 113 498 ± 91 0.285 
 Time min 6.7 ± 2.7 2.8 ± 0.4 0.001 
 1 x 16 Gy (n=3)  9.9 ± 1.6 3.4 ± 0.4 - 
 2 x 10 Gy (n=3)  6.8 ± 1.8 2.7 ± 0.2 - 
    3 x 9 Gy   (n=4)  4.3 ± 0.7 2.5 ± 0.1 - 
 
Table 2 summarizes the results of gamma analyses between film measurements and 
calculations, averaged over all 6 FFF cases (3 lung and 3 vertebral cases). For both individual 
arcs and sum plans, gamma evaluations show high agreement between measurements and 
calculations (Fig. 3), with on average, less than 1% of the analyzed area within the ROI 
exceeding gamma value >1. 
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Figure 1. Comparison of dose distributions in sagital planes for vertebral FF plan (left) and FFF plan (right), 
with planning target volume outlined in red. The DVH shows similar target coverage and OAR sparing between 
6MV FF plan (squares) and 10MV FFF plan (triangles). 
 
 
Figure 2. Comparison of dose distributions in tranverse planes for lung FF plan (left) and FFF plan (right), with 
planning target volume outlined in red. The DVH shows similar PTV coverage and OAR sparing between 6MV 
FF plan (squares) and 10MV FFF plan (triangles). 
 
Table 2: Summary of gamma analysis for 6 patients 
 Gamma > 1, % Maximum Gamma Mean Gamma 
CCW 0.22 ± 0.45 1.09 ± 0.18 0.26 ± 0.06 
CW 0.47 ± 0.57 1.27 ± 0.26 0.27 ± 0.04 
Sum 0.32 ± 0.46 1.12 ± 0.18 0.25 ± 0.06 
    
 
 
Figure 3. Dose profiles in sagital direction (left) of a spine patient that has been treated using FFF plans. The 
measured dose profile is indicated by red line, and green line indicates the calculated dose. In the gamma 
evaluation (right), the area with gamma value close to 1 and larger than 1 appear in white and red, respectively.  
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Discussion 
 
The main finding of our study was that use of FFF beams significantly reduces beam delivery 
times for RapidArc lung and vertebral SBRT plans, without compromising plan quality. A 
vertebral SBRT plan with a mean PTV dose of 19 Gy could be delivered in 3.8 minutes, as 
opposed to 10.8 minutes when using flattened beams. Although it has been suggested that 
FFF beams are suitable for small fields due to the relatively flat profile in the middle of the 
beams [17], we found that they are also suitable for treating large PTV’s, with a length >10 
cm and volume >200 cm3, using RapidArc delivery.   
 
The shorter beam delivery time may reduce the risk of intrafraction patient motion and tumor 
displacement [18]. However, use of very high dose rates requires a stringent patient 
monitoring protocol during beam delivery as a maximum dose of 1 Gy can be delivered 
within the course of 2.5 seconds. The extent of dosimetric error caused by positional shifts 
for certain periods of time during FFF RapidArc delivery warrants further investigation and 
will be the subject of future study. As an initial step to addressing these concerns, we have 
implemented first-generation positional monitoring using the Real-time Position 
Management™ (RPM) system (Varian Medical Systems, Palo Alto). The RPM system 
monitors the respiratory motion using the signal from a box of infrared reflective markers 
positioned on the patient’s chest, and displays the periodical motion signal on the screen in 
the control room. In amplitude gating mode, threshold levels are set tightly around the regular 
breathing amplitude of the patient to trigger beam-off if motion exceeds the threshold level. 
Although the system only allows for the setting of thresholds in one direction, all three 
directions are being monitored. We acknowledge that the accuracy of this system is 
compromised by the fact that the marker displacement reflects breathing-induced motion and 
shifts in patient position.  
 
The results of our plan comparison are consistent with previous studies of FFF delivery [10-
11]. Plan conformality, PTV coverage and OAR sparing were comparable for FF and FFF 
plans. The accuracy of the calculation algorithm in homogeneous media does not appear to be 
compromised by the absence of the flattening filter, considering the good agreement between 
calculated and measured dose distributions of FFF plans in a homogeneous phantom.   
 
For vertebral metastases, the mean and maximum PTV doses were slightly higher for FFF 
plans (p<0.05). However, these are consistent with the ongoing RTOG 0631 protocol, which 
allows doses in the PTV to be inhomogeneous as long as ≥90% of the target volume receives 
the prescribed dose [16]. 
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Some issues relating to the optimal beam energy for FFF delivery were also studied. Previous 
work suggested that a 6 MV FFF beam was more suitable for lung SBRT, due to the sharper 
dose fall-off in comparison to a 10 MV FFF beam [19]. However, lack of beam hardening 
with flattening filter causes a lower mean energy in FFF beams, which can increase the dose 
at the build-up region [9]. Vassiliev et al. have also shown that the 20% isodose line moves 
closer to the surface in FFF lung SBRT plans as compared to FF plans, which were generated 
using same beam energy [10]. Therefore, we compared 6 MV FF plans with the 10 MV FFF 
plans and this revealed no significant increases in skin dose in all vertebral FFF plans studied, 
although it should be noted that we routinely use a skin structure to limit skin doses during 
treatment planning. An additional advantage of using 10 MV FFF beams is the higher 
maximum dose rate of 2400 MU/min possible on Varian linacs, compared to 1400 MU/min 
for 6 MV FFF beams. Treatment time is an important consideration in SBRT, especially for 
patients with painful vertebral metastases and an imaging intervention approximately every 5 
minutes has been recommended during delivery in order to verify stability of the tumor and 
critical structure location [18]. Although the beam delivery time has already been 
considerably reduced with use of RapidArc [4], we found that it could be reduced further to 
less than 4 minutes using the combination of RapidArc and FFF beams. For lung SBRT, FFF 
beams shortened the delivery time for all fractionation schemes with the exception of that 
using a 7.5 Gy fraction size. The delivery time of the latter was limited by our use of 2 full 
arcs for delivery, and a gantry speed of minimum 70 seconds per rotation.  
 
For vertebral metastases, accurate patient positioning throughout the entire treatment delivery 
is essential due to the high dose gradient between target and spine. In order to perform 
positional verification at approximately every 3 minutes, arcs with delivery time of > 3 
minutes were avoided. For some FF vertebral SBRT plans, e.g. plans with high fraction dose 
or plans with longer delivery time due to excessive modulation, 3 arcs were used for dose 
delivery as use of only 2 arcs would have resulted in delivery times per arc exceeding 3 
minutes. With use of FFF beams, the 3rd arc was no longer necessary as delivery took less 
than 2 minutes per arc. Consequently, all vertebral FFF plans in this study required only 2 
arcs and furthermore, imaging for setup verification can be performed between the arcs 
within approximately 2 minutes of initial positioning.  
 
The MU required for the FFF lung plans were on average 8.3% higher. This increment was 
not present in vertebral cases due to the reduction of the total number of arcs in FFF plans. 
On average, lung FFF plans needed more MU because of the same definition of MU being 
used for the two types of beams, each with different profiles.  The output of both beams was 
calibrated such that 1 MU gave an absorbed dose of 1 cGy at central axis at a depth of dose 
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maximum (Dmax) for a field size of 10 x 10 cm2, and for a source-to-axis distance of 100 
cm. Due to the cone-shaped dose profile in FFF beams, points located away from the central 
axis will receive less than 1 cGy for 1 MU, as opposed to flattened beam. Consequently, FFF 
plans will require more MU to give the same amount of dose for points located away from 
central axis. For both beam energies, the treatment units produce same radiation pulses at 360 
pulses per second. The removal of flattening filter increases dose per pulse, from 0.46 
mGy/pulse in 6MV FF beams to 1.11 mGy/pulse in 10MV FFF beams. Therefore, even with 
more MU, fewer pulses are needed for FFF beams to deliver same level of dose as for the FF 
beams. Consequently, energy consumption by the linear accelerator is reduced, as FFF beams 
require fewer electron pulses from the accelerator to deliver the same dose as for FF beams. 
 
For the delivery of RapidArc SBRT to mobile lung tumors, we previously reported that the 
leaf interplay was not dosimetrically significant for single-fraction treatments when the dose 
was delivered using two full rotational arcs [20]. With the use of FFF beams, SBRT fraction 
doses were still delivered over a minimum of 2.5 minutes due to the limitation of gantry 
speed rotation. While this may provide sufficient averaging effect to minimize any possible 
over-or underdosages arising from interplay effects, if the fraction doses were delivered with 
only one single arc or 2 half arcs, we cannot exclude the possibility of an interplay effect 
caused by the faster delivery.  
 
One potential limitation of this study is that the FF-FFF comparisons were carried out using 
different machines with different MLCs. The use of an HD-MLC has been compared to a 
standard MLC by other authors, and in general the results showed marginal improvement 
with the HD-MLC [21]. In this study, any improvement might therefore favor the FF plans, 
however, no significant dosimetric gains were observed in target coverage or OAR sparing.    
 
The use of FFF beams has sparked interest in the radiobiological effects of high dose rate 
delivery. Work on cell lines by some groups suggested no significant differences in cell 
survival with the use of higher instantaneous dose rates [22], although others have found that 
higher doses per pulse for FFF beams had a greater reduction in clonogenic cell survival for 
glioblastoma cell lines [23]. Our clinical patients are under routinely followed up using 
standard radiological schemes and only long-term follow-up will reveal the clinical 
implications, if any, of FFF treatments. 
 
In this study, film dosimetry verification for the FFF plans showed excellent results, where 
less than 1% of the area within the ROI failed the gamma criterion of 3% dose difference and 
2 mm DTA, which is comparable to results obtained for flattened beams [24]. A reliable 
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patient specific measurement is important for the configuration of the calculation algorithm. 
Small adjustments for the dosimetric leaf gaps and transmission factor may be required to 
achieve good agreement between calculations and measurements of RapidArc delivery. It 
should be noted, though, that the measurements were only performed in a homogeneous 
polystyrene phantom, and the influence of density inhomogneities for the AAA dose 
calculation algorithm on FFF beams was not investigated.  
 
Conclusion 
 
The beam-on time for lung and vertebral SBRT can be shortened with the combination of 
RapidArc and a FFF beam. Plan quality and measured accuracy were considered clinically 
comparable between 10 MV FFF and 6MV FF plans. 
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8.1 Intensity modulated arc therapy 
 
Interest in rotational delivery of radiotherapy has surged in recent years. A literature search in 
PubMed using the terms: “arc therapy” or “RapidArc” or “VMAT” or “Tomotherapy”, 
retrieved 67 entries between 1995 and 1999, 158 entries in 2000 – 2004, 592 entries in 2005 
– 2009, and 548 entries in 2010 and 2011.  Simple rotational delivery of radiotherapy was 
first introduced in the 1950s [1-4]. Subsequently, Takahashi reported on the use of rotational 
conformal radiotherapy technique using a dynamic field shaping multileaf collimator (MLC) 
in 1965 [5]. In the 1980s, Brahme et al. developed the concept of radiation beam intensity 
modulation using rotational therapy techniques [6]. The use of serial tomotherapy on a 
commercial radiation delivery system was introduced and clinically implemented in 1994, 
where radiation dose is delivered using a small fan-beam MV-source with a binary MLC, 
rotating around the patient. A further evolution of arc therapy with a linear accelerator (linac) 
was intensity modulated arc therapy (IMAT), which was proposed by Yu in 1995 [7]. Unlike 
tomotherapy which uses rotating narrow fan beams around the patient who is translated 
through the bore of the tomotherapy machine, IMAT delivered radiation using rotational cone 
beams of varying apertures shaped using MLC on a standard linac.  
 
Many other terms or acronyms have been used to describe arc delivery on a conventional 
linear accelerator (linac), including simplified intensity modulated arc therapy (SIMAT) [8], 
aperture modulated arc therapy (AMAT) [9], arc-modulated radiation therapy (AMRT) [10], 
sweeping window arc therapy (SWAT) [11], and volumetric modulated arc therapy (VMAT) 
[12]. The difference between the above mentioned techniques is mostly in the planning 
methods used, which vary in planning efficiency and dose conformity. Currently, arc delivery 
techniques have been adopted by different manufactures under various trade names: 
RapidArcTM (Varian Medical Systems, Inc., Palo Alto, CA, USA), Elekta VMATTM (Elekta, 
Inc., Stockholm, Sweden) and SmartArcTM (Philips, Inc., Andover, MA, USA). All arc 
intensity modulated delivery techniques will be collectively referred in this discussion as 
rotational IMRT. All these techniques demonstrate the capability of creating highly 
conformal treatment plans and efficient dose delivery, using variable dose rates, gantry 
speeds and field openings shaped with a multi-leaf collimator (MLC).  
 
The idea of rotational IMRT has generated much interests and debate. Bortfeld et al. agued 
that single-arc IMRT only has a potential use for relatively simple cases and that the delivery 
efficiency is not significantly larger compared to static IMRT techniques [13]. The authors 
also reported that Tomotherapy can achieve dose distributions much closer to the desirable or 
ideal scenario than rotational IMRT for complex target volume wrapped around an organ at 
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risk. Using slice by slice delivery, Tomotherapy indeed shows the advantage of obtaining 
conformal dose distributions optimized per slice. However, the use of very fine slice 
thickness prolongs both delivery and planning time, and the delivery requires a dedicated 
machine. In contrast, rotational IMRT can be carried out on a conventional linac. By using a 
collimator angle around 45°, combined with MLC motion and variable dose-rate, Otto 
showed that rotational IMRT can achieve similar high quality dose distributions [14]. This 
statement was supported by Verbakel et al. 2009, who reviewed the clinical application of 
rotational IMRT for treatment of complex PTVs such as locally advance head-and-neck, 
whole brain radiotherapy with a simultaneous integrated boost, and stereotactic radiotherapy 
for stage I lung tumors [15].    
 
8.2 Planning studies of Rotational IMRT  
 
This thesis describes research on the use of RapidArc for stereotactic body radiotherapy 
(SBRT). Several technical aspects such as planning routine, accuracy of the calculation 
algorithms and dose delivery have been addressed. Since fast delivery is the most significant 
advantage of RapidArc compared to conventional IMRT, clinical implementation of SBRT in 
stage I lung tumors was a priority at our department. Due to the complex fields arrangement 
and large fraction doses, treatment delivery using other techniques can extend up to 100 
minutes [16,17]. Such prolonged treatment delivery times is associated with a high risk of 
substantial intrafraction tumor base line shift [18,19]. In chapter 2, we evaluated the plan 
quality and delivery efficiency of RapidArcTM in comparison to other conventional 
techniques, including fixed-beam delivery. Although rotational IMRT has been extensively 
compared to other conventional linac-based delivery techniques for different treatment sites 
[20-26], few studies have compared RapidArc with other treatment modalities such as 
tomotherapy [27-30] or cyber-knife [31,32].  
 
For planning of various treatment sites, mostly non-SBRT, comparison of  
RapidArc with other linac-based techniques, e.g. IMRT, 3D-CRT, or DCA, showed 
equivalent or better plan quality, both in terms of target dose conformity or dose homogeneity 
and organs at risk (OAR) sparing. Dosimetric comparisons of different rotational IMRT 
techniques with other treatment modalities, e.g. Tomotherapy and Cyberknife, have been 
performed. Rong et. al. compared a series of patients planned using single arc rotational 
IMRT and helical Tomotherapy (HT) [28]. Although rotational IMRT plans achieved 
superior dose conformity, HT plans achieved higher target dose homogeneity and lower dose 
to the critical structures. Superior OAR sparing with tomotherapy has also been described for 
prostate cancer [30] and head-and-neck cancer [33]. However, another study comparing HT 
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to rotational IMRT for eighteen cases, including prostate, head-and-neck and lung cancer, 
reported comparable plan quality between the 2 techniques [29]. The Wagner’s 
conformity/gradient index (CGI), an index that integrates both dose conformity and dose 
gradient components, calculated for thirteen cranial stereotactic radiosurgery cases was the 
highest for rotational IMRT plans, followed by Cyberknife and Tomotherapy [32]. Another 
study evaluated twelve patients with intracranial lesions planned using rotational IMRT 
technique, reported that the conformity indices were similar to those reported in other articles 
using different modalities, including Cyberknife and Tomotherapy [31].  Based of the studies 
from different groups, the results were inconsistent and it remains difficult to draw fixed 
conclusions from these reports. In addition, the clinical relevance of the observed dosimetric 
differences was also unclear. 
 
The inconsistency reported in the abovementioned results may be accounted for by planner 
bias and difference in choices of planning objectives and reported parameters between the 
treatment planning studies. An example of planner bias is that there is a risk of systematically 
producing better plans with one technique if it is also that preferred by the planner. Plan 
quality is also dependent on a planner’s experience, the understanding of the planning system 
and dose constraints, the amount of time and effort invested, and the treatment planning 
system itself. A comparison of rotational IMRT plans created using two different TPS, 
Monaco (Elekta VMATTM solution), and Eclipse (Varian RapidArcTM solution), to other 
treatment techniques (IMRT and Tomotherapy), found that the quality of rotational IMRT 
plans varied between the two planning systems [33]. While target dose homogeneity and 
optimization time were in favor of RapidArcTM plans, VMATTM plans achieved better sparing 
of the critical structures. This is often a trade-off: better sparing of OAR may go at the 
expense of target coverage. For a planning study involving different TPS, the plan quality 
may also slightly vary due to differences in the algorithms used for final dose calculation. 
Hasenbalg et. al. evaluated the performance of the collapsed-cone convolution (CCC) 
algorithm in MasterPlan TPS (version 1.5, Nucletron BV, Veenendaal, the Netherlands) and 
the anisotrpic analytical algorithm (AAA) in Eclipse TPS (version 7.5.22.0, Varian Medical 
Systems, Palo Alto, CA) against Monte Carlo simulations. They evaluated three lung and 2 
breast cancer cases and reported a better overall accuracy in CCC than AAA [34].  In chapter 
5, we also showed that even within a single TPS, the use of different versions of AAA and 
choice of calculation grid resolutions can greatly influence the calculation accuracy.  
 
For most rotational IMRT techniques, the number of arcs used for delivery can influence the 
plan quality. While some planning studies were carried out using rotational IMRT with single 
arc [23,28], many studies have shown that multiple arcs can improve both target 
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coverage/homogeneity and the sparing of OAR [26,27,35,36]. For complex cases, Verbakel 
et. al. [21] showed that the use of 2 arcs provided better dose homogeneity and delivery 
accuracy. The trade-off between the number of arcs and the quality of plans is a prolongation 
of delivery time and a potential increase in number of monitor units (MU). Nonetheless, a 
two arcs rotational IMRT plan still demonstrates much higher delivery efficiency compared 
to conventional IMRT or most three dimensional conformal radiotherapy (3D-CRT) 
techniques [21,27,36]. Fast delivery is the only consistent finding in all planning studies 
comparing rotational IMRT to other delivery techniques, except for single arc dynamic 
conformal arc delivery technique.  
 
For IMRT treatment of lung tumors, interplay effect between the leaf and tumor motion is a 
major concern. Although it has been suggested that a large dosimetric deviation exhibited in 
one single fraction could be averaged out after 30 fractions, this finding might not be 
applicable in SBRT which uses only limited number of fractions. In chapter 4, we reported 
that for rotational IMRT delivered over more than 2.5 minutes using 2 arcs, the dosimetric 
impact caused by interplay effect can be neglected.  
 
8.3 Delivery efficiency of rotational IMRT 
 
A fast treatment delivery is relevant from many points of view. Aside from improving patient 
comfort and accelerated patient throughput, it also improves treatment accuracy by reducing 
the risk of intrafraction baseline shifts. With an increasing number of patients undergoing 
lung SBRT treatments [37], rotational IMRT allows for treatment of more patients per day, 
and it enables more attention to be paid towards imaging procedures for accurate patient 
setup within standard time slots on the linac. Our department began treating lung SBRT cases 
using RapidArcTM in September 2008 (Fig. 1). In the period up to December 2011, a total of 
554 lung SBRT cases have been treated using rotational IMRT, with an average of more than 
200 per year in 2010 and 2011. In most Dutch centers, SBRT or stereotactic ablative 
radiotherapy (SABR) has rapidly replaced 3D-CRT and an increasing proportion of 
radiotherapy centers are able to perform SBRT. In recent years, a shift has been observed 
towards the use of SBRT in previously untreated elderly patients and treatment of high risk 
surgery patients [37]. Consequently the efficiency of the treatment planning is also getting 
more important. An automatic optimization that no longer requires to define the constraints 
for each plan can accelerate the process and reduce planners bias. Such techniques should be 
developed in the future.   
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At the department, different ‘risk-adapted’ fractionated schemes have been used, varying 
from 3 to 8 and later to 12 fractions, depending on tumor size and location. Fig. 1 illustrates 
the number of lung SBRT patients treated with RapidArc, using the different ‘risk adapted’ 
fractionation schemes used at VU university medical center. There is a clear trend towards 
increasing numbers of patients treated using 12 x 5 Gy regime. This group of patients usually 
has large centrally located tumors. Before the implementation of RapidArc, large tumors 
measuring > 6 cm were often technically not possible to treat using SBRT in our institute due 
to field size restriction on the designated linac. Zhang et. al. compared 3D-CRT with 
rotational IMRT for a total of 15 SBRT lung patients with PTV size ranging up to 160.8 cm3. 
In addition to a higher averaged conformity index for 3D-CRT technique, the standard 
deviation reported is also larger with this technique, implying that dose conformity varies 
more with the size, shape or location of the target. VMAT technique showed significant 
improvement in terms of dose conformity, volume of lung minus gross tumor volume (GTV) 
receiving 5 and 20 Gy (V5Gy and V20Gy), and mean lung dose [38].  
 
 
Figure 1. Total number of lung SBRT cases, treated using different fractionation schemes in VU university 
medical central using RapidArc.  
 
8.4 Treatment planning for lung SBRT 
  
At our department, tumors < 70 cm3 are usually planned using 2 arcs with avoidance sectors, 
i.e. defining a sector of the arcs without radiation delivery (Fig. 3), optimized sequentially. 
As described in chapter 2, the sequential planning routine is to overcome the shortcoming of 
the dose calculation accuracy of the optimizer in the low density of lung tissue, where the 
second arc will compensate for any underdosage areas in the first arc, which are usually 
located at the low density region. A drawback of this planning routine is the increased 
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planning workload.  In addition, a second arc may have higher dose modulation. In chapter 4 
and 5, we showed that an arc requiring higher dose modulations is subject to more calculation 
errors and interplay effect. In head and neck tumors, Richard et al. showed that target dose 
homogeneity is in favor of simultaneous planning than sequential. However, it is less relevant 
for lung SBRT where the PTV dose is likely to range between 90 – 140% of the prescribed 
dose [39]. 
 
 
Figure 2. Suggested planning routines for large tumors > 70 cm3 with two full arcs with avoidance sector, partial 
arc or half arc, optimized sequentially or simultaneously.  
 
For large tumors, the preferred planning routine differs slightly from that of small tumors. 
Fig. 2 illustrates optimal planning routines used for tumors > 70 cm3, depending on the 
location of the target. In planning cases where the internal target volume (ITV) is in contact 
with the chest wall (area 3 and 4 in Fig. 2), simultaneous planning is possible as the PTV 
contains relatively little low density lung tissue. For a posteriorly located peripheral target, 
e.g. in area 4 or 6 in Fig. 2, the ideal arc setting for a target located in the left lung should be 
an arc starting from e.g. 225º to 315º, avoiding any incoming beams from the contralateral 
lung as show in Fig. 3. However, due to machine limitations, the gantry is not able to rotate 
crossing the 180 degree gantry angle. A solution to the problem is a full rotational arc with 
avoidance sector. The extra control points from 225º to 180º provide more freedom for the 
optimizer to create a more conformal plan, but it requires a full gantry rotation, which 
prolongs the delivery time compared to a partial arc setting. Thus, for cases where the extra 
control points would not provide a better plan quality, e.g. target located at area 1, 2, 3 or 5 in 
Fig. 2, a partial arc or half arc delivery is preferable.  
 
Another beam setting restriction is the use of couch rotation. For delivery of 3D-CRT and 
IMRT, it has been demonstrated that non-coplanar delivery can provide better treatment plans 
than coplanar delivery. In rotational IMRT, the use of couch rotation may lead to larger 
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optimization freedom. Zhang et al. demonstrated better plan quality using non-coplanar 
rotational IMRT compared to the corresponding technique using a coplanar arc setting [38]. 
For a full gantry rotation, use of a large couch rotation is restricted to avoid collision with the 
gantry, however, several institutes have successfully implemented non-coplanar delivery 
using several partial arcs. This arc arrangement can be useful for treatment delivery for large 
lung tumors where the target volume is in contact with several OAR. However, use of couch 
rotations will require technologists entering the treatment room in between the arcs, which 
will again prolong treatment time. For most tumors treated with SBRT, e.g. small tumors 
located in the middle of the lung, at some distance of important OAR, couch rotation will not 
provide much benefit as highly conformal plans can be achieved with coplanar arcs. 
 
 
 
Figure 3. In order to cover the arc indicated in the figure, a full rotational arc with avoidance sector has to be 
used. The machine prohibits the gantry to rotate crossing the 180° gantry angle. The dot indicates the starting 
position of the gantry rotation.  
 
8.5 Use of flattening filter free beams 
 
Although rotational IMRT techniques achieve high quality plans, reports have also shown 
that this technique distributes low dose to a larger part of the body [23,40], which 
theoretically may lead to a higher risk of secondary malignancies [41]. On the other hand, 
rotational IMRT uses significantly less MU per treatment compared to other conventional 
linac-based IMRT techniques [21,23,42,43]. The amount of dose caused by linac head scatter 
and leakage radiation is correlated with the number of MU delivered, and this could also be 
associated with the risk of inducted secondary malignancies. In modern radiotherapy, the 
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basic beam data is taken into account during the computerized optimization process. 
Consequently, a flattened beam is not necessary and recent interest in radiation delivery using 
flattening filter free beams has shown decreasing dose to parts of the body far away from the 
tumor by reducing radiation head leakage [44-46].  
 
The removal of the flattening filter in the treatment head increases the dose rate, and 
consequently, shortens the delivery time. Although fast delivery is favorable for SBRT lung 
treatments, possible interplay effects between MLC leaf motion and target motion have to be 
evaluated. FFF delivery using 2 full rotational arcs may still provide sufficient averaging 
effect to minimize any possible dosimetric impact caused by the interplay effect, as a 
consequence of the minimum delivery time being restricted by the standard maximum gantry 
rotation speed of 4.8º per second. Nonetheless, for treatment using high dose regimes, e.g. 3 
fractions of 18 Gy, part of the arc may be delivered at the highest dose rate of 2400 MU/min. 
And for plans consisting of only a single arc or 2 partial arcs, the magnitude of possible 
under-/over-dosage within the PTV caused by the interplay effect still has to be evaluated.  
 
The use of fast delivery also sparked interests in the radiobiological effects of this approach. 
The implementation of IMRT was followed by study of its influence on cell survival due to 
prolonged delivery times. Wang et al. reported that the total treatment delivery time during 
one single fraction may have significant impact on the cell survival [47]. Similar modeling 
studies have also predicted increased cell survival following radiation delivery over a 
prolonged IMRT delivery time [48,49]. Bewes et al. investigated the effects of fraction 
delivery time and instantaneous dose rate on cell survival and reported that only increasing 
total delivery time leads to a progressive increase in cell survival. No correlation was found 
between cell survival and instantaneous dose rate of the beam between 138 – 830 Gy/min 
[50]. Similar results have also been reported by Sørensen et al. for dose rates of up to 29.91 
Gy/min [51]. Lohse et al., however, reported that the FFF beams is more efficient in reducing 
clonogenic cell survival compared to standard FF beams, especially for higher doses 
delivered in one single fraction [52]. They attributed this effect to the higher dose per pulse in 
FFF beams rather than the shorter delivery time. However, our group investigated three 
human cancer cell lines and showed no difference in cell survival following irradiation using 
conventional flattening beam and FFF beams, with maximum dose rate of 600 and 2400 
MU/min, respectively [53], for fraction doses of up to 12 Gy.  
 
The contradictory data indicates a need for further investigations on the radiobiological 
implications of using high dose rate radiation delivery. In addition, the reaction of healthy 
tissue cells to higher dose rates should also be investigated. An early clinical assessment of 
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SBRT treatments using FFF beams was carried out in 70 consecutive patients with various 
primary and metastatic lesions [54]. With a minimum of 3 months follow up, no increase in 
acute toxicity was observed. Longer clinical follow up is still needed to evaluate both late 
toxicity and tumor control outcomes. 
 
8.6 Future perspectives 
 
Prior to SBRT treatment delivery, cone-beam computed tomography (CBCT) scans are 
performed and the images are subsequently registered with the planning CT scan based on the 
position of the tumor. Although a tolerance of 1 mm and 1 degree is used throughout the 
treatment, the accuracy of CBCT has been previously reported to be within 1 and 2 mm [55].  
Achieving sub-millimeter set-up accuracy is a challenge. Some systems have specified sub-
millimeter accuracy, which have been achieved mostly in phantom measurements [56-58]. 
With an ultra-fast delivery, accurate and fast on-line patient positional verification devices 
are needed to ensure accurate delivery in patients. In chapter 7, we demonstrated that fast 
delivery is more susceptible to a large dosimetric impact caused by unexpected motion during 
vertebral SBRT even for short periods. Delivery with high dose rate beam requires careful 
patient monitoring during treatment delivery and any large and detectable motions should be 
corrected quickly.  
 
The position of the tumor during treatment delivery can be tracked with the use of certain 
markers placed in the tumor (such as radioactive or electromagnetic markers). If an invasive 
procedure such as marker implantation is not possible, the tumor can tracked using accurate 
on-board imaging devices as such available on a MRI-accelerator which is currently under 
development [59]. In addition, a novel method called digital tomosynthesis (DTS) is being 
explored for providing fast online positional monitoring. It is a technique for reconstructing 
3D images by using only limited number of kV projection images and it has been 
investigated for several applications such as chest imaging [60] and breast imaging [61]. 
Comparison of DTS to cone-beam CT in determining lung tumor position showed agreement 
within 2 – 3 mm in most cases [62] In vertebral SBRT, DTS is investigated for spine tracking 
during rotational IMRT delivery and a preliminary phantom study showed the possibility of 
detecting intrafraction shifts within 0.5 mm [63]. Further development of this technique can 
certainly assist FFF rotational IMRT in delivering an accurate dose distribution.  
 
In our department, all lung SBRT patients are treated during quiet uncoached breathing. 
Local control reported for this technique are similar to those of breath-hold techniques 
[64,65]. However, breath-hold [66] or respiratory gating [67] techniques may be able to 
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further reduce the treatment margins used to account for target motion [68], and 
consequently, increase normal tissue sparing. Using a deep inspiration breath-hold technique, 
Barnes et al. reported a 32.5% reduction in the volume of lung receiving 20 Gy or more 
compared to free breathing radiation delivery [69]. Decreasing the range of tumor motion 
during beam-on can also reduce the risk of interplay effects between MLC leaves and target. 
An extended treatment time may accompany the use of such techniques. With high delivery 
efficiency of FFF rotational IMRT, these techniques are now feasible within an acceptable 
time frame.  
 
Conclusion 
 
Rotational IMRT delivery is a novel extension to IMRT techniques. The capability of 
achieving high plan quality and fast dose delivery has increased the role of rotational IMRT 
in the practice of radiotherapy. Although many studies have demonstrated its advantages for a 
variety of treatment sites, application in different treatment sites still requires new evaluation 
of optimization objectives and possible dosimetric gains. In addition, more clinical reports on 
patients treated using this technique are also needed. 
 
With the wide-spread interests in rotational IMRT, new developments will further improve 
the efficiency of plans optimization and accuracy of treatment delivery. A good 
understanding of this technique and its potential risk is important. Even with a possibility of 
faster delivery using FFF beams with higher dose rate, all aspects such as the quality of plans, 
delivery accuracy and treatment time should be carefully weighted.  
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Summary 
 
Intensity modulated radiotherapy (IMRT) is a relatively new approach of radiation dose 
delivery technique, introduced in the early 1990s. Although it is capable of delivering highly 
conformal dose distribution, it suffers from several drawbacks, including long treatment 
times, high integral doses and difficulty in selecting optimal beam orientations. RapidArc™ 
(Varian Medical Systems), as a form of volumetric modulated arc therapy, is an extension of 
IMRT which delivers the dose in a 358° gantry rotation. During delivery, an IMRT dose 
distribution can be generated using varying dose rates, gantry speeds and leaf apertures 
created using a dynamic multi-leaf collimator. A fast delivery using RapidArc is particularly 
attractive for stereotactic body radiotherapy (SBRT) treatment which features precise 
delivery of high radiation dose in only one or few fraction(s). Until 2008, SBRT at our 
institute was delivered using non-IMRT techniques, consisting of multiple non-coplanar 
static beams. With the introduction of the new RapidArc approach, it became essential to 
optimize the treatment planning process, and to evaluate the plan quality.  
 
For many years, SBRT delivery was commonly performed using one of the following three 
techniques, namely 3-dimensional conformal radiotherapy (3D-CRT), dynamic conformal arc 
(DCA), and IMRT. In Chapter 2, we describe comparative dose distributions and delivery 
times between RapidArc with other common SBRT delivery techniques for stage I non-small 
cell lung cancer (NSCLC) measuring < 70 cm3, which represents the size of tumors 
commonly treated with this technique. To account for the shortcomings in accuracy of the 
optimizer calculation algorithm used in an earlier version of the treatment planning software 
in low density media, RapidArc plans were optimized using planning objectives of 5 – 10% 
higher than the prescription dose for the planning target volume (PTV). In addition, all plans 
consisted of at least 2 arcs, where the second arc was optimized by referring to the 
anisotropic analytical algorithm (AAA) calculated dose distribution of the first arc. The 
comparative study indicated that RapidArc achieved the highest dose conformity and shortest 
delivery time. However, it increased the volume of contralateral lung receiving 5 Gy, V5, 
when compared to 3D-CRT. In order to limit the dose, high priority optimization objectives 
were used for the contralateral lung, often in combination with the use of an avoidance sector 
or partial rotation arc.  
 
Clinical toxicity is uncommon following SBRT for tumors of 70 cm3 or smaller. In chapter 
3, we studied early clinical toxicity in patients with large tumors (PTV ranging from 87 – 286 
cm3), following SBRT using RapidArc, and correlated these with different dosimetric 
parameters. The rates of symptomatic radiation pneumonitis (RP) were higher than those 
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reported for small tumors (28% vs. <10%). Contralateral lung V5 was the best predictor as all 
patients with contralateral lung V5 > 26% developing RP. Limiting beams coming from 
contralateral direction can effectively reduce the contralateral lung V5, but it might also 
increase the dose to chest wall. The analysis suggested that plans should be prioritized to 
spare the contralateral lung, while also limiting doses to other organs at risk, also because in-
house data show very limited chest wall toxicity for lung SBRT. 
 
For IMRT delivery in mobile tumors, the possibility of interplay between tumor motion and 
multileaf collimator (MLC) motion is a key concern. During IMRT or RapidArc delivery, 
both the MLC leaves and tumor are constantly moving, with the interplay effect potentially 
leading to under- or over-dosage in the PTV.  In Chapter 4, we evaluated the dosimetric 
accuracy between delivered and calculated dose distributions and the possible interplay 
effects of SBRT RapidArc delivery for patients with stage I lung cancer. Film dosimetry 
confirmed that RapidArc accurately delivered the calculated dose distribution. For most of 
the clinical plans, the dosimetric impact of the interplay effect can be neglected. Plans with 
higher modulation in combination with great tumor motion can possible exhibit clear 
dosimetric errors in a single arc, but the use of 2 arcs delivery per fraction reduces the errors 
by providing an averaging effect, where the large fraction doses are delivered over at least 33 
breathing cycles.  
 
Since its introduction in 2008, the RapidArc planning software has undergone a number of 
refinements and improvements. Chapter 5 analyses the accuracy of AAA for a variety of 
small fields in homogeneous and heterogeneous media, and for RapidArc plans. Two 
versions of AAA; AAA version 8.6.15 (AAA8) and AAA version 10.0.25 (AAA10), 
calculated using grid resolutions of 2.5 mm and 1.0 mm were investigated. Both versions 
performed better in muscle tissue equivalent material than in lung tissue equivalent material. 
AAA 10 improves the accuracy of dose calculations, and calculation grid of 1.0 mm is 
superior to using 2.5 mm. Plans consisted of large number of small MLC segments, thus 
more modulation and numbers of monitor unit (MU), and PTV volume which contains 
relatively large area of low density tissues are more likely to result in calculation errors. 
Calculations using 1 mm grid resolution are recommended for these plans, although the 
calculation times may increase by a factor of 5. During optimization, a highly modulated plan 
should be avoided by using a suitable upper MU constraint.  
 
The risk of tumor displacement is increased with prolonged treatment times, such as those 
associated with SBRT, and faster delivery may facilitate treatment accuracy. In most linear 
accelerators, a flattening filter is inserted within the treatment head to create a flattened beam, 
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a feature which was necessary to facilitate the forward treatment planning approach used in 
conventional planning techniques. The introduction of IMRT led to use of an inverse 
planning approach which accounts for basic beam data by a computerized optimization 
process. Consequently, flattened beams are no longer needed to facilitate planning. A 
standard linac operating without a flattening filter can achieve higher output dose rate, and 
thus, potentially reduce treatment delivery time.  Chapter 6 reports the use of flattening filter 
free (FFF) beams in RapidArc delivery for SBRT of NSCLC and vertebral metastases. 
Compared to plans generated using a standard flattened (FF) beam, FFF plans significantly 
reduce beam delivery times by a factor of up to 2.5, with fraction doses of up to 18 Gy 
deliverable within 4 minutes. No major dosimetric differences were observed between the 2 
techniques and measured FFF plans showed high agreements with calculated dose 
distributions. These findings suggest that faster delivery using FFF is beneficial for patients 
as the quality of plans are not compromised. 
 
With a fast treatment delivery using RapidArc and FFF beams, a stringent patient monitoring 
protocol during beam delivery is required as a great amount of doses can be delivered over a 
short period of time. Any intra-fraction motions, even sub-millimeters misplacements, over a 
few seconds may be subjected to large dosimetric errors. Chapter 7 studies the possible 
dosimetric impact on spinal cord and target volume caused by intra-fraction shifts for short 
period of times during the delivery of RapidArc plans for SBRT of vertebral metastases using 
both FFF and FF beams. For shifts of 1 – 5 mm over 5 – 30 seconds, delivery using FFF 
beams constantly exhibited larger dosimetric deviations compared to those delivered using a 
flatten beam. For shifts of 5 mm over 10 seconds, the maximum dose of the spinal cord could 
increase by more than 50% in a FFF arc, which is a factor of 2 larger than those observed in 
the corresponding FF arc. This underscores the importance of accurate patient positioning 
during treatment delivery using a high dose rate FFF beam and any unexpected motions 
should be corrected quickly.  
 
Chapter 8 discusses the role of volumetric modulated arc therapy in radiotherapy treatment. 
Many planning studies have compared this technique with other methods, including those 
modalities such as Tomotherapy and Cyberknife. Although dosimetric differences were not 
consistent, volumetric modulated arc therapy constantly exhibited superior treatment delivery 
efficiency. Its clinical implementation in different treatment sites has also triggered 
discussions on the optimal fields (arcs) arrangement, such as number of arcs, coplanar or non-
coplanar beam, full rotational or partial arcs. A better understanding of plans quality, delivery 
accuracy and toxicity patterns for patients treated using this technique may assist the process 
of treatment planning. While delivery using FFF beams can further reduce treatment time, the 
Summary 
________________________________________________________________________________________________________________ 
 139 
potential risk associated high dose rate delivery should also been considered such as the 
possible interplay effect and dosimetric errors caused by sudden shifts. During delivery, a fast 
reaction time is essential to identify any intrafraction motions and interrupt the treatment to 
re-align the patient. Finally, future developments will have to emphasize more on the 
development of fast and precise real-time image guidance system.   
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Samenvatting 
 
Intensity modulated radiotherapy (IMRT) is een relatief nieuwe benadering van 
bestralingstechniek, geïntroduceerd in de vroege jaren 90 van de vorige eeuw. Intensiteit 
gemoduleerde radiotherapie (IMRT) biedt de mogelijkheid om zeer conforme 
dosisverdelingen te creëren, maar kan tevens diverse nadelen hebben, zoals langere 
behandeltijden, hoge integrale doses en problemen bij het kiezen van de optimale 
bundelconfiguratie. RapidArc™ (Varian Medical Systems), een vorm van volumetrisch 
gemoduleerde arc therapie is een uitbreiding van IMRT die de dosis tijdens één of meer 
gehele of gedeeltelijke gantry rotaties aflevert. Tijdens de bestraling kan een IMRT 
dosisverdeling worden gegenereerd door het variëren van de intensiteit van de gegenereerde 
straling, de snelheid van de gantrybeweging, en openingen van de multileaf collimator 
(MLC). Het gebruik van RapidArc maakt het mogelijk de dosis in veel kortere tijd toe te 
dienen, en is daardoor bijzonder geëigend voor stereotactic body radiotherapy (SBRT). SBRT 
is een vorm van radiotherapie waarbij een uiterst precieze afgifte van een hoge stralingsdosis 
in slechts één of enkele fracties wordt uitgevoerd voor doelgebieden van beperkte grootte. 
Tot 2008 werd in het VU medisch centrum SBRT uitgevoerd gebruikmakend van niet-IMRT 
technieken, bestaande uit meervoudig niet-coplanare statische bundels. Met de invoering van 
de nieuwe RapidArc techniek werd het optimaliseren van de treatment planning, alsook het 
evalueren van de kwaliteit van de plannen met een sterke inhomogeniteit, essentieel. 
 
Jarenlang was het gebruikelijk SBRT behandelingen uit te voeren met een van de volgende 
drie technieken: 3-dimensionale conforme radiotherapie (3D-CRT), dynamische conforme 
arc (DCA), and IMRT. In Hoofdstuk 2, beschrijven we een studie naar de vergelijking van 
dosisverdelingen en bestralingstijden tussen RapidArc en andere technieken bij kleine en 
middelgrote (<70 cm3) stadium I non-small cell lung cancer (NSCLC). Om rekening te 
houden met de tekortkomingen in de nauwkeurigheid van het optimalisatiealgoritme in media 
met lage dichtheid in een eerdere versie van de software, werden de RapidArc plannen 
geoptimaliseerd door gebruik te maken van 5-10% hogere dosisvoorschriften in de 
optimalisatie dan de voorgeschreven dosis voor het planning target volume (PTV). 
Bovendien maakten alle plannen gebruik van 2 bogen, waar de tweede boog werd 
geoptimaliseerd door te refereren aan de door het anisotropic analytical algorithm (AAA) 
berekende dosisverdeling van de eerste boog. De uitkomst van deze vergelijkende studie was 
dat met RapidArc de hoogste dosisconformiteit en de kortste bestralingstijden bereikt konden 
worden. Echter, vergeleken met 3D-CRT, werd het volume van de contralaterale long dat 5 
Gy of meer ontvangt (V5), groter. Om deze dosis te verlagen werd hoge prioriteit gegeven 
aan het optimaliseren van de doelstellingen voor de contralaterale long. Dit werd meestal 
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gedaan in combinatie met het gebruik van een sector in de boog zonder dosisafgifte zodat niet 
direct door deze long gestraald wordt of gebruik van een gedeeltelijke boog. 
 
Klinische toxiciteit is ongebruikelijk na SBRT bij tumoren van 70 cm3 of kleiner. In 
hoofdstuk 3 werd de vroege klinische toxiciteit bij patiënten met grote tumoren (PTV binnen 
grenzen van 87 – 286 cm3), na SBRT met RapidArc onderzocht, en gerelateerd aan 
verschillende dosimetrische parameters. De kans op symptomatische radiatie pneumonitis 
(RP) was hoger dan voor kleine tumoren (28% vs. <10%). De V5 van de contralaterale long 
(V5cl) bleek de beste voorspeller. Alle patiënten met V5 > 26% RP ontwikkelden, terwijl het 
bij geen van de patiënten met een lagere V5 optreedt. Door beperking van de bestraling vanuit 
de contralaterale richting kan de V5 effectief worden beperkt, maar mogelijk vergroot dit de 
dosis in de borstwand. De analyses maakten aannemelijk dat behandelplannen voorrang aan 
het sparen van de contralaterale long moeten geven, waarbij de beperking van de doses voor 
de andere risico lopende organen op de tweede plaats komt, mede omdat de data in ons 
instituut een zeer beperkte borstwand toxiciteit laat zien bij long SBRT.  
 
Bij IMRT bestraling van bewegende tumoren is het belangrijk om te weten dat gelijktijdige 
beweging van de tumor en beweging van de multileaf collimator (MLC) geen effect heeft op 
de dosis in de tumor. Tijdens IMRT of RapidArc bestraling zijn zowel de MLC-bladen als de 
tumor voortdurend in beweging, wat  mogelijk tot lokale onder- of overdosering in het  PTV 
kan leiden. In hoofdstuk 4 evalueren we de dosimetrische nauwkeurigheid tussen de 
berekende en geleverde dosisverdelingen en de dosimetrische effecten van mogelijke 
samenspel van RapidArc bestraling voor patiënten met een stadium I long kanker. 
Filmdosimetrie bevestigde dat RapidArc de berekende dosis accuraat afleverde. Voor de 
meeste klinische behandelplannen kan het dosimetrische gevolg van het samenspel effect 
worden genegeerd. Behandelplannen met een hogere modulatie in combinatie met een grote 
tumor kunnen mogelijk dosimetrische fouten in een enkele boog vertonen, maar het gebruik 
van 2 bogen per fractie reduceert die fouten doordat er een middelend effect optreedt, daar de 
dosis worden toegediend gedurende tenminste 33 ademcycli.  
 
Sinds de introductie in 2008, heeft de RapidArc treatment planning software een aantal 
verfijningen en verbeteringen ondergaan. Hoofdstuk 5 analyseert de nauwkeurigheid van het 
AAA algoritme voor een variëteit van kleine velden in homogene en heterogene media, en 
voor RapidArc behandelplannen. Bestralingsplannen werden in twee software versies (AAA 
versie 8.6.15 (AAA8) en AAA versie 10.0.25 (AAA10), berekend, met gebruikmaking van 
berekeningsresoluties van 2.5 mm en 1.0 mm. Beide berekenden de dosis nauwkeuriger in 
aan spierweefsel gelijkend dan in aan longweefsel gelijkend materiaal. AAA10 verbeterde de 
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nauwkeurigheid van de dosisberekeningen, en een berekeningsresolutie van 1.0 mm was 
beter dan een resolutie van 2.5 mm. Behandelplannen die een groot aantal kleine MLC 
segmenten bevatten, met daardoor een grotere modulatie en een groter aantal monitor 
eenheden (MU), en een PTV volume met een relatief groot gebied van weefsel met lage 
dichtheid, leiden tot fouten in de berekening. Berekeningen die gebruik maken van een 1 mm 
berekeningsresolutie worden aanbevolen voor deze behandelplannen, hoewel hierdoor de 
berekeningstijden met een factor 5 langer kunnen worden. Gedurende de optimalisatie moet 
sterke modulatie worden vermeden door passende beperkingen voor het maximum aantal MU 
te gebruiken.  
 
De kans op kleine bewegingen van de patiënt tijdens een bestraling wordt vergroot door 
langere behandeltijden, zoals die voorkomen bij SBRT. Een kortere bestralingstijd kan leiden 
tot een grotere nauwkeurigheid van de behandeling. In de meeste lineaire versnellers is een 
filter in de behandelkop geplaatst om een afgevlakte en meer homogene stralingsbundel te 
vormen. Deze functie was nodig bij conventionele planning technieken. De invoering van 
IMRT leidde tot het gebruik van een computergeoptimaliseerde planning met inhomogene 
bundels, waardoor deze filter niet langer noodzakelijk is. Zonder filter kan een hoger 
dosistempo worden afgeven waardoor de behandeltijd sterk kan worden verkort. Hoofdstuk 
6 gaat over het gebruik van afvlakkingsfilter vrije (FFF) bundels in RapidArc bestraling voor 
SBRT van kleine longtumoren en wervelmetastasen. Vergeleken met behandelplannen die 
werden gegenereerd met standaard afgevlakte (FF) bundels, verminderen FFF plannen de 
stralingstijd met maximaal een factor 2.5, met het grootste effect voor SBRT van 
wervelmetastasen en bestralingen met hoge fractiedosis. Een fractiedoses van 18 Gy kan 
worden  afgeleverd in 3 minuten. Er werden geen grote dosimetrische verschillen gevonden 
tussen deze twee technieken en de gemeten FFF plannen lieten een grote overeenstemming 
zien met de berekende dosisverdelingen. Deze uitkomsten suggereren dat een snellere 
bestraling, gebruik makend van FFF, beter is voor patiënten aangezien de kwaliteit van de 
behandelplannen er niet door wordt aangetast. 
 
Bij een snelle bestralingsbehandeling met behulp van RapidArc en FFF stralingsbundels is 
het noodzakelijk een stabiele positie van de patiënt goed te monitoren gedurende de 
bestraling omdat een grote dosis in een zeer korte tijd wordt toegediend. Elke intrafractie 
beweging, zelfs verplaatsingen van een millimeter gedurende enkele seconden, kan al leiden 
tot grote dosimetrische fouten. Hoofdstuk 7 handelt over een studie naar de mogelijke 
dosimetrische gevolgen op het ruggenmerg en de tumor, veroorzaakt door kortdurende 
intrafractie verschuivingen tijdens RapidArc behandelingen van wervelmetastasen met FFF 
en FF bundels. Bij verschuivingen van 1-5 mm gedurende 5-30 seconden tijdens gebruik van 
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FFF bundels werden steeds grotere dosimetrische afwijkingen gezien dan met FF bundels. Bij 
verschuivingen van 5 mm gedurende 10 seconden tijdens een FFF boog kan de maximale 
dosis in het ruggenmerg met meer dan 50% doen toenemen. Dit is een factor twee groter dan 
de toename die we zien in een vergelijkbare FF boog. Dit onderstreept het belang van een 
nauwkeurige controle van de patiënt positionering gedurende de bestralingsbehandeling met 
FFF bundels bij SBRT en elke onverwachte beweging zal snel moeten worden gecorrigeerd. 
 
Hoofdstuk 8 bediscussieert de rol van RapidArc bij conventionele en stereotactische 
radiotherapie, en de samenhang van de verschillende onderzoeken in deze thesis. Veel studies 
hebben rotationele IMRT vergeleken met andere methoden, waaronder conventionele IMRT, 
Tomotherapy en Cyberknife. Hoewel de dosimetrische verschillen niet consistent waren, 
vertoonde RapidArc steeds een veel grotere efficiëntie van bestraling. Daarnaast heeft de 
klinische implementatie van deze techniek voor verschillende tumoren discussie uitgelokt 
over de optimale configuratie, zoals het aantal bogen, coplanaire of niet coplanaire bundels, 
volledig of gedeeltelijk roterende bogen. Een beter begrip van de kwaliteit van het 
behandelplan, de bestralingnauwkeurigheid en de toxiciteitpatronen zouden het treatment 
planningsproces kunnen ondersteunen. Terwijl bestraling, gebruik makend van FFF bundels, 
de behandeltijd verder kan beperken, moet ook het mogelijke risico dat gepaard gaat met 
hoge dosis bestraling in aanmerking worden genomen, zoals het mogelijke samenspel effect, 
en dosimetrische fouten, veroorzaakt door intrafractiebeweging van de patient. Gedurende de 
bestraling is snel reageren essentieel om iedere intrafractie beweging te registreren en 
eventueel de positie van de patient te corrigeren.  
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